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Abstract
Chronic obstructive pulmonary disease (COPD) is the co-occurrence of chronic bronchi-
tis and emphysema. This leads to a limitation of the flow of air to and from the lungs,
causing shortness of breath. The role of bacterial infection in COPD remains unclear.
Since there is a growing body of evidence about the presence of core microbial
communities in the lower respiratory tract, the main purpose of this work was to inves-
tigate their structure more detailed in healthy individuals and their changes linked with
COPD. Bronchoalveolar lavages obtained from 9 healthy individuals and 9 stable COPD
patients were analyzed using molecular biology-based approaches such as terminal re-
striction fragment length polymorphism (T-RFLP) and sequencing. Additionally, the in
situ detection of bacteria was performed on the tracheal tissue sections.
Sequencing data, supported by T-RFLP analysis, showed the presence of core micro-
biome in the lower respiratory tract. The key genera were Prevotella, Sphingomonas,
Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veillonella, Staphylococcus,
and Streptococcus. Despite this fact the observed variability in the microbial composition
was so high that no pattern could be established both for healthy individual and COPD
patient cohorts. On the other hand, the presence of the genera Mycoplasma (6 positive
samples), Pseudomonas (5 positive samples), and Staphylococcus (5 positive samples)
was highly correlated with disease. Fluorescence in situ hybridization with universal
eubacterial oligoprobe EUB338 demonstrated the subepithelial manner of microbial
distribution.
In conclusion, non-cultural methods can be used to identify the microbial biota of
the airways.
i
Zusammenfassung
Die chronisch obstruktive Lungenerkrankung (englisch: chronic obstructive pulmonary
disease, COPD) ist definiert durch das gleichzeitige Auftreten einer chronischer Bron-
chitis und eines Lungenemphysems. Dies führt zu einer Einschränkung des Luftflusses
sowohl bei der Ein- als auch bei der Ausatmung, was Kurzatmigkeit verursachen kann.
Die Rolle von bakteriellen Infektionen bei COPD ist bislang nicht vollständig geklärt.
Da immer mehr Hinweise auf die Anwesenheit von beständiger mikrobieller Be-
siedelung in der unteren Atemwegen hindeuten, war es der Hauptziel dieser Arbeit,
diese Besiedlungen näher zu untersuchen, sowohl im gesunden Zustand als auch bei Pa-
tienten mit COPD. Bronchoalveoläre Lavagen von 9 gesunden Personen und 9 stabilen
COPD-Patienten wurden mit molekularbiologischen Methoden wie der Sequenzierung
und der Analyse terminaler Restriktionsfragmentlängenpolymorphismen (T-RFLPs) un-
tersucht. Zusätzlich wurden in situ Bakterien in Gewebeschnitte der Trachea nachgewie-
sen.
Sequenzierungsdaten und T-RFLP-Analysen liefern Hinweise auf die Präsenz eines
beständigen Mikrobioms in die unteren Atemwegen. Die Hauptgattungen sind Pre-
votella, Sphingomonas, Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veil-
lonella, Staphylococcus und Streptococcus. Dennoch ist die beobachtete Variabilität der
mikrobiellen Zusammensetzung so hoch, dass ein typisches Muster weder für gesunde
Individuen noch für COPD-Patienten festgestellt werden konnte. Andererseits korreliert
die Anwesenheit von Gattungen wie Mycoplasma (6 positive Proben), Pseudomonas (5
positive Proben) und Staphylococcus (5 positive Proben) stark mit der Krankheit. Die
Fluoreszenz-in-situ-Hybridisierung mit EUB 338 (englisch: universal eubacterial oligo-
probe) zeigt eine klare mikrobielle Verteilung.
Zusammenfassend, konnte in dieser Arberit gezeigt werden, dass nichtkulturelle Ver-
fahren verwendet werden können um das Mikrobiom der Atemwege zu identifizieren.
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1 Introduction
The airways, which are also referred to as the “conducting portion” of the respiratory
system, delivers air to the lungs (known as the “respiratory portion”), where gas ex-
change takes place. The conducting portion consists of the nose, pharynx, larynx, tra-
chea, and bronchi, whereas the respiratory portion consists of the bronchioles, alveolar
ducts, alveolar sacs, and alveoli. It is also convenient to divide the tract into the upper
respiratory tract (nose and pharynx) and the lower respiratory tract (larynx, trachea,
bronchi and lungs). The conducting portion, apart from the bronchi, is colonized by
microbes [180].
Chronic obstructive pulmonary disease (COPD) is a respiratory disease associated
with chronic inflammation of the lung leading to tissue destruction and emphysema.
Frequent bacterial infections of the respiratory tract of COPD patients and chronic bron-
chitis are known to contribute to the progress and exacerbations of COPD.
Bacterial colonization of the respiratory tract plays a crucial role in the disease pro-
gression, as chronic colonization with harmful bacteria contributes to an ongoing in-
flammation of the lung. Respiratory pathogens are a part of the pulmonary microbial
community which have a complex structure and composition. Since harmful microbes
compete with a huge variety of standard microbiota representatives in the upper and
lower respiratory tract, it is of great interest to monitor the changes in species com-
position between the healthy state and disease [188, 166, 161, 142, 139]. Moreover,
constant exposure of the respiratory tract with the non-sterile air leads to microbe-
microbe and microbe-host interactions. However, human airway microbiota, particu-
larly that present in the context of pulmonary disease, remains largely uncharacterized
[79], as routinely used classical culture methods do not deliver any information about
non-cultivable species. In contrast, molecular biology based approaches that do not de-
pend on cultivating the microbes have high resolution and would allow deep analysis
of respiratory samples.
1.1 Chronic obstructive pulmonary disease
COPD has been defined by the Global Initiative for Chronic Obstructive Lung Disease
(GOLD): COPD is a preventable and treatable disease with some significant extra-
pulmonary effects that may contribute to the severity in individual patients. Its pul-
monary component is characterized by airflow limitation that is not fully reversible.
The airflow limitation is usually progressive and associated with an abnormal inflam-
matory response of the lung to noxious particles and gases [1]. COPD is not one single
disease but an umbrella term used to describe chronic lung diseases that cause limita-
tions in lung airflow. The most important risk factors for COPD are tobacco smoking,
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indoor air pollution (e.g. biomass fuel used for cooking and heating), outdoor air pol-
lution, occupational dusts and chemicals (vapors, irritants, and fumes). COPD is not
just simply a “smoker’s cough”, but an under-diagnosed and life threatening lung dis-
ease. According to the World Health Organization (WHO), it is estimated that in 2007
about two hundred ten million people had COPD and in 2005 three million people died
of COPD. The WHO predicts that COPD will become the third leading cause of death
worldwide by 2030 (http://www.who.int/respiratory/copd/en/).
Pathological changes characteristic of COPD are found in the proximal airways, pe-
ripheral airways, lung parenchyma and pulmonary vasculature. They include chronic
inflammation with increased numbers of neutrophils, macrophages, and cluster of dif-
ferentitaion 8 positive (CD8+) T lymphocytes [115] in different parts of the lung, and
structural changes resulting from repeated injury and repair. The key changes include
mucus gland hyperplasia and epithelial damage, whereas subepithelial collagen depo-
sition, angiogenesis, increased smooth muscle and increased proteoglycan deposition
are less significant [24]. The inflammation of the respiratory tract of COPD patients
appears to be an amplification of the normal inflammatory responses of the respiratory
tract to inflammatory stimuli, such as cigarette smoke and bacterial stressors. Some
patients develop COPD without smoking. This phenomenon has been linked with α1-
antitrypsin deficiency [107]. α1-antitrypsin is an acute-phase protein, which is the pro-
totypic member of the serpin super family and a major inhibitor of serine proteases such
as neutrophil elastase and proteinase-3. It plays an important role in limiting host tissue
injury by proteases at sites of inflammation [172]. There is also a relative lack of infor-
mation about the inflammatory mechanisms involved in exacerbations of COPD [1]. In
mild and moderate exacerbation there is an increase of neutrophil and in some studies
also eosinophil number in sputum and in the airway wall [177]. This is associated with
increased concentrations of certain mediators, such as TNF-α and interleukin 8 (IL-8)
and an increase of biomarkers of oxidative stress.
The pathological characteristics of the respiratory tract of COPD patients and smok-
ers, such as chronic inflammation, result in an impaired lung defense against pathogens
which increases susceptibility to pulmonary infections. Two distinct infection cycles in
COPD patients are described, that contribute to the progressive loss of lung function:
1. During the acute cycle, the lung becomes more susceptible to repeated acute mu-
cosal infections of the airways from viruses and bacteria, leading to episodes of
increased inflammation and worsened symptoms, which are clinically diagnosed
as acute exacerbations of (AECOPD) [148].
2. A less well-recognized infection cycle in COPD is the chronic cycle. In this case
microbial colonization results in chronic inflammation and lung destruction, con-
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ceptualized as the “vicious circle hypothesis” (see Figure 1). This hypothesis posits
that once impaired innate lung defense allows microbial pathogens to become es-
tablished in the lower respiratory tract, the microbial pathogens further impair
mucociliary clearance and lung defense due to increased mucus secretion, dis-
rupting ciliary activity and airway epithelial injury [147, 162].
Thus, microbial colonization of the lower airways in patients with COPD can perpet-
uate itself. Furthermore, the chronic presence of bacteria in the lower airways is not
innocuous; rather, it induces inflammation and can contribute to progressive airflow
obstruction and lung damage characteristic of this disease [175, 101].
Figure 1: Model of bacterial pathogenesis in COPD (proposed by SETHI)
[148]. Once impaired the host immune defence becomes incapable of pre-
venting the colonization by airway pathogens. This leads to exacerbation
— worsening of common state and to intensification of symptoms. COPD
exacerbation can be defined as “an event in the natural course of the dis-
ease characterized by a change in the patient’s baseline dyspnea, cough,
and/or sputum, that is beyond normal day-to-day variations” [1]. Mu-
cosal damages caused by inflammatory reaction on the pathogen promote
the switching of infection to chronicity. In the case of successful elimina-
tion of pathogen raises the risk of acquisition of another bacterial strain
[159]. RAKHIMOVA et al. in her molecular epidemiological study showed
that COPD patients are susceptible to frequent turnover or loss of clones
of P. aeruginosa, whereas cystic fibrosis patients are chronic carriers of the
same strains [126].
HURST and colleagues investigated the relationship of airway inflammation and sys-
temic inflammation for the presence of bacterial pathogens in exacerbated COPD pa-
tients [80]. On the cellular level M. catarrhalis as well as H. influenzae are able not
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only to efficiently adhere to but also to invade the airway epithelium [158]. The ability
to invade epithelial cells has been discussed as a useful bacterial strategy to colonize
the respiratory tract and to avoid extracellular immune recognition by PRRs such as the
transmembranous toll-like receptors (TLRs) [5]. SLEVOGT et al. could show that M.
catarrhalis enters cultured respiratory cells by a trigger-like uptake mechanism. Fur-
thermore, cell surfaces as well as intracellular located PRRs are involved in the pro-
inflammatory immune response induced by this bacterium [158]. Their data demon-
strated an involvement of both TLR2 and nucleotide-binding oligomerization domain-
containing protein 1 (NOD1) in the IL-8 response to M. catarrhalis [58]. NOD1 silenc-
ing reduced the IL-8 production to approximately 30–35%, which resembled the deficit
in nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB ) activation in
NOD1 knockout cells.
One of the key points in the COPD management program is prevention and treat-
ment of exacerbations [64]. AECOPD play a crucial role in the course of the disease
as they negatively impact on morbidity, mortality, health care costs and health related
quality of life [12]. AECOPD are associated with pulmonary and systemic inflammation
including the increases of serum C-reactive protein and blood leukocytes level [26, 85].
About 50% of AECOPD have a bacterial etiology, which is confirmed by several studies
[44, 135, 83]. Bacterial microbes most commonly associated with AECOPD are H. in-
fluenzae, M. catarrhalis, S. pneumonia, C. pneumoniae, M. pneumoniae, and Legionella
species [44, 83, 108]. Also viruses such as rhinovirus, respiratory syncytial virus, in-
fluenza virus A, B, and parainfluenza virus 1–3 are often detected in AECOPD.
The identification of the microorganism associated with an exacerbation is impor-
tant to further understand the relationship between microbes and exacerbations and
to develop antimicrobial therapeutic strategies. Current methods to identify associ-
ations between microbes and AECOPD are limited. Routine cultural microbiological
methods do not allow the identification of viruses and intracellular pathogens. In ad-
dition, results can be obtained only after several days. Methods based on nucleic acid
testing (NAT) such as the polymerase chain reaction (PCR) have been developed re-
cently [41, 118]. Sputum samples are commonly used as starting material for PCR.
This method can be also performed on nasopharyngeal aspirates or samples obtained at
bronchoscopy [170].
The collection of exhaled breath condensate (EBC) allows one to noninvasively de-
termine parameters that are associated with physiological or disease processes [76]. In
AECOPD, chemical and inflammatory markers were found to be altered, including pH,
IL-1β, IL-6, IL-8, IL-10, IL-12 p70, or TNF [60, 92], however, there is only limited data
on the detection of microorganisms based on NAT from EBC [57, 84].
The aim of the present study was to evaluate the feasibility and sensitivity of NAT-
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based assays to detect exacerbation-associated pathogens from EBC. Patients with AE-
COPD were recruited and underwent the collection of EBC and sputum. PCR-based
detection assays for various bacterial and pathogens were developed and applied to
these materials.
1.1.1 Role of the airway epithelial barrier
The airway epithelium together with alveolar macrophages and dendritic cells play a
major role in the initial recognition of bacterial products [16, 61] getting into the lower
airways with the air. Since some of these products are potent proinflammatory stimuli
it is extremely important for the immune system to distinguish between pathogens and
non-pathogenic commensals [174]. This prevents the development of constant inflam-
mation and forms tolerance against harmless microbiota (see Figure 2). This process
becomes much more intriguing when taking into account that commensals often share
their surface molecules with pathogens [47]. Epithelial cells are equipped with very
sensitive recognition tools-toll like receptors (TLRs), NOD like receptors (NLRs) and
retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) which recognize a broad va-
riety of microbial structural components [5, 7, 14, 68, 72, 95, 182, 153, 131]. Detailed
description, as well as structural and functional analysis of microbial pattern recognition
receptors can be found in reviews of AKIRA and MEDZHITOV [5, 106]. After recogni-
tion of pathogenic bacteria proinflammatory pathways are activated and cellular com-
ponents of the adaptive and innate immunity are recruited to the infection site. One
key regulator in this process is the NF-κB which translocates from the cytoplasm into
the nucleus and activates pro-inflammatory genes in epithelial cells and macrophages
[34, 74, 113, 50].
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Figure 2: Mechanisms underlying the inflammation in COPD. Airway ep-
ithelium has complex structure: consists of at least seven diverse cell types
interacting with each other by means of tight junctions [18, 33, 69]. More-
over, epithelial calls can deliver the signals into the underlying tissues tak-
ing part in the mechanisms of innate and adaptive immune defence. The
key transmitters of the signals are dendritic cells. Once pathogenic bac-
terium (e.g., S. pneumoniae, P. aeruginosa [71]) has activated particular
pattern recognition receptors on or in epithelial cells, the proinflamma-
tory signaling pathways are activated. This results mainly in IL-1, IL-6 and
IL-8 production [65, 90]. These cytokines induce chemotaxis to the site
of infection in its target cells (e.g., neutrophils, dendritic cells [48, 129]
and macrophages [4]). On the other hand, representatives of standard
microbiota cause only weak signaling preventing the inflammation. The
mechanism of distinguishing between harmless and harmful bacteria on
the molecular as well as on physiological levels is not completely under-
stood.
In contrast, harmless bacteria do not cause the translocation of NF-κB into the nu-
cleus thus preventing the inflammation although they can express the same microbe-
associated molecular patterns (MAMPs) [96, 47]. One possible mechanism explaining
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this effect was suggested by NEISH showing that non-pathogenic S. typhimurium PhoPc
and S. pullorum are able to prohibit the ubiquitination of NF-κB inhibitor molecule nu-
clear factor of NF-κB light polypeptide gene enhancer in B-cells inhibitor alpha (IκB-κ)
[112]. Another explanation of commensal tolerance of the epithelium refers to the
post-translational modification of a protein by the covalent attachment of one or more
ubiquitin (Ub) monomers. The inhibition of ubiquitination leads to reduction of inflam-
mation, because only polyubiquitinated (IκB-κ is targeted for degradation by the 26 S
proteasome, allowing NF-κB translocation to the nucleus and activation the transcrip-
tion of effector genes (for example IL-8). Moreover KUMAR et al. showed that probiotic
bacteria such as Lactobacilli are able to modulate the activity of the Ub-proteasome
system via inducing reactive oxygen species (ROS) production in epithelial cells [94].
In mammalian cells, ROS have been shown to serve as critical second messengers in
multiple signal transduction pathways in response to proinflammatory cytokines [97].
Bacterially induced ROS causes oxidative inactivation of the catalytic cysteine residue of
Ub12 resulting in incomplete but transient loss of cullin-1 neddylation and consequent
effects on NF-κB and β-catenin signaling. Another commensal species, B. thetaiotaomi-
cron, attenuates pro-inflammatory cytokine expression by promoting nuclear export of
NF-κB subunit RelA, through a peroxisome proliferator activated receptor γ (PPAR-γ)-
dependent pathway [88]. PPAR-γ target transcriptionally active Rel A and induce early
nuclear clearance limiting the duration of NF-κB action.
The balance between pathogens and commensals is extremely important in the
maintenance of homeostasis in the respiratory tract [78].
1.2 Microbiome of the respiratory tract
The airways are continually exposed to a multitude of microorganisms, some of which
are able to persist in and even colonize the respiratory tract. This is possible due to
the presence of nutrients, oxygen, and optimal growth temperature. There are several
host-derived nutrient sources for microbial residents: secretions from airway epithelial
cells (especially goblet cells) and submucosal glands, transudate from plasma. Each day
about 20ml to 100ml of airway surface liquid (ASL) is produced [6]. 90% of its mass
consists of water. ASL contains mucins (MUC5AC and MUC5B), albumin (ranging from
0.48mg/ml in the trachea to 0.73mg/ml in the bronchi), prealbumin, immunoglobu-
lins, α1-antitrypsin, α2-macroglobin, gaptoglobin and other proteins. Lipids are present
at an average concentration of 1% (mostly phospholipids). A range of glycosamino-
glycans are present, including heparin sulphate, heparin, chondroitine sulphate, and
hyaluronate. The main ions present are Na+, K+, and Cl-. In the alveolar regions of the
lungs the alveolar lining fluid (ALF) differs from ASL. ALF contains albumin (9mg/ml),
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phospholipids, vitaminC, vitamin E, reduced glutathione, transferrin (324µg/ml), and
ceruloplasmin (22.2µg/ml). A major constituent of ALF is a mixture of surface-active
compounds known as pulmonary surfactant, which lowers the surface tension of the
fluid [180].
Table 1: Key members of the standard microbiota of the respiratory
tract
Nasal cavity Nasopharynx Trachea Lungs
Bacteroides sp. Bacteroides H. influenzae Fusobacterium sp.
Diphteroides sp. Diphteroids Neisseria sp. P. adiacens
H. influenzae H. influenzae S. pneumoniae V. atypica
M. pneumoniae M. catarrhalis Staphylococcus sp. ?
Proteus sp. N. meningitidis
S. epidermidis Streptococci
S. aureus
Moreover, the pool of available nutrients is increased by the activities of some mem-
bers of the microbiota. Macromolecular components of respiratory secretions (proteins,
glycoproteins, lipids, nucleic acids) are converted to nutrients (e.g. carbohydrates,
amino acids). Thus, the metabolic activity of present bacteria allow for the colonization
of new species (see Figure 3). The upper respiratory system is populated by numer-
ous species of bacteria: aerobes, facultative anaerobes, aerotolerant, and anaerobes are
all represented [54]. Therefore, the secretions usually contain large numbers of diph-
teroids, micrococci, staphylococci and smaller numbers of other bacteria that normally
inhabit the environment, such as Bacillus sp. About 20% of healthy humans also carry
S. aureus in the nasal cavity. Further inside the nasal passages, the microbial popula-
tion resembles that of the nasopharynx. The nasopharynx contains large numbers of
microorganisms, mostly α-hemolytic Streptococci of the viridans group, nonhemolytic
Streptococci, M. catarrhalis and diphteroids (see Table 1). Anaerobic Gram-negative
bacteria, including species of bacteroides, are also normally present in large numbers in
the nasopharynx.
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Fatty acids Aminoacids Sugars
Nutrients for microbes colonizing respiratory tract
Figure 3: Major metabolic conversions which provide the nutrients for
members of indigenous respiratory microbiota [180]. Since different bac-
teria have various metabolic characteristics the easiest way to provide all
of them with nutrients is to convert large complex molecules into smaller
universal constituents. In the case of complex microbial communities the
most unpretentious members with a wide spectrum of enzymes supply oth-
ers with fatty acids, amino acids and sugars. Not only new species can be
attracted in that way, but total bacterial load of existing community can be
increased.
Moreover, commonly pathogenic bacteria such as Streptococcus, H. influenzae and
N. meningitidis are often found in this area, especially during the cooler seasons of the
year. More virulent species such as S. pyogenes, M. pneumoniae, C. diphteriae and B.
pertussis are sometimes found, but only in a small percentage of healthy individuals.
Microorganisms in the entire lower tract in the alveolar regions of lungs, except the
most common pulmonary pathogens are not detected using conventional culture-based
approaches. In diagnostic microbiology, the classification of bacteria present within
clinical samples requires the prior culture of bacterial species on selective nutrient me-
dia. However, the use of selective media and growth conditions requires assumptions
to be made concerning which species will be present. Consequently, sputa or bron-
choalveolar lavages (BALs) are assayed routinely for only a limited number of bacterial
species considered important, including H. influenzae, S. pneumoniae, M. catarrhalis
and P. aeruginosa. HILTY et al. have recently published their data concerning the al-
terations of pulmonary microbiota in asthma and COPD patients. They found that the
bronchial tree contains a characteristic microbial biota that differs between health and
disease [75]. Pathogenic Proteobacteria, particularly Haemophilus sp., were much more
frequent in bronchi of adult asthmatics or patients with COPD than controls, and Bac-
teroidetes were more frequent in controls.
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1.2.1 Bacterial colonization and standard microbiota in COPD
SETHI marked out five different pathways by which bacteria can contribute to the ae-
tiopathogenesis of COPD [163]:
• 10–30% of acute exacerbations of COPD with consequent morbidity and mortality
are caused by bacteria
• Invasion and persistence of bacterial pathogens in respiratory tissues alerts the
host response to noxious stimuli such as tobacco smoke inducing the chronic in-
flammatory response and thus contributing to the pathogenesis of COPD
• Patients with COPD develop hypersensitivity to bacterial antigens which enhances
airway hyperreactivity and induces eosinophilic inflammation
• Acute severe childhood respiratory tract bacterial infections damage the immature
lung, impairs lung growth thereby predisposing the individual to the development
of COPD
• Chronic colonization of the tracheobronchial tree by bacterial pathogens ampli-
fies the chronic airway inflammation present in COPD and accelerates progressive
airway obstruction (see Figure 1)
Chronic bacterial colonization is a promising area of research due to its possible implica-
tion in the pathogenesis of COPD [148]. ZHANG et al. showed that patients with moder-
ate to severe COPD have bacterial colonization in lower airways even at the stable status
[187]. Among the bacterial pathogens, H. influenzae was the most frequently isolated
pathogen. Both sputum culture and bacterial colony counts could be associated with
the severity of colonization. Patients with chronic colonization were associated with a
significantly increased frequency of exacerbations (p=0.04) and decline of forced ex-
piratory volume in one second (FEV1) (p=0.035). An observational study of BANERJEE
et al. performed with 67 subjects revealed that those with opportunistic pathogens (H.
influenzae, S. pneumoniae, M. catarrhalis, H. parainfluenzae, S. aureus, P. aeruginosa and
K. pneumoniae) in their sputum exhibited higher neutrophil differential counts, greater
sputum supernatant levels of IL-8, leukotrieneB, TNF and neutrophil elastase than the
non-colonized subjects [20]. The bacteria in the airways are in a constant state of
turnover, releasing extracellular products, as well as undergoing lysis with the release
of a variety of proteins, lipopoligosaccharides and peptidoglycans. Lipopoligosaccha-
ride (LPS) is a potential proinflammatory stimulus that can lead to development of em-
physema. It can therefore be assumed that “colonization” is a low-grade smouldering
infection that induces chronic airway inflammation. In the large airways such inflam-
mation would contribute to mucus production and in the small airways to respiratory
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bronchitis and progressive airway obstruction [163, 128]. H. influenzae, S. pneumoniae
and M. catarrhalis are responsible for 10–30% of exacerbations.
1.2.2 Bacteria in clinical samples
Within the body of a healthy adult both the beneficial and harmful influences of bacteria
are often due to their interactions in complex communities [22]. The major coloniza-
tion sites are various mucosal surfaces (such as in the gastrointestinal tract, the geni-
tourinary tract, the oral cavity, the nasopharynx, the respiratory tract) and the human
skin [121]. These communities, however, remain largely unstudied, leaving their in-
fluence upon human development, physiology, immunity, and nutrition almost entirely
unknown.
In practical terms, to identify the genus and species of a bacterium the major four
types of approaches are used: direct techniques (such as Gram and acid-fast stain), cul-
ture techniques (involve cultivating a specimen in nutrient medium), detection of micro-
bial by-products (Voges–Proskauer, gelatinase, hydrogen sulfide production, phenylala-
nine deaminase tests) and molecular biological techniques [54]. Although the advan-
tages of traditional culture methods are obvious (they are quantitative, isolates can be
typed or fingerprinted, antibiotic sensitivity tests can be done, isolates can be archived),
they are slow, require skilled and experienced personnel and only cultivable in the used
culture medium bacteria can be detected. Culture media are capable of providing the
in vitro growth of only about 1% of the total range of bacterial species present. Fur-
thermore, it is questionable whether or not they are actually quantitative [122]. To
solve these difficulties, molecular microbiological techniques were developed during
the 1960s and 1970s in research laboratories. As a result, over the past one or two
decades the identification of the organisms that are infectious to humans have been
greatly facilitated by the development and application of specific molecular nucleic acid
amplification methods and hybridization (probe) tests [120]. The polymerase chain re-
action (PCR) is among the most popular of these methods. PCR is a technique which
allows amplification of a single or a few copies of a piece of DNA across several orders of
magnitude, generating thousands to millions of copies of a particular DNA sequence. In
general, speed, increased sensitivity and the fact that these methods can be done with
inadequately stored specimens are the main reasons to use molecular-based techniques
[13, 181, 133]. In addition, databases and phylogenetic trees can be readily generated
and automation is possible. High-throughput use of these tests, however, is still some-
what restricted due to the significant costs involved (reagents, apparatus, personnel),
the fact that confirmatory tests are often necessary, as bacteria cannot be isolated for
further studies, and the methods are not yet widely accepted for medicolegal testing.
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1.3 Molecular techniques to identify microbial species
1.3.1 The rRNA encoding genes
By using PCR to amplify sequences that are specific to a certain species of microorgan-
ism and then determining the nucleotide sequence of that specific sequence, one can
compare that sequence with the sequences of bacteria that have already been identi-
fied. Bacteria having very similar sequences of nucleotides must be closely related. 16 S
rRNA gene is such a sequence in the microbial genome, which holds a special place in
the characterization of microbial communities.
The bacterial ribosome consists of two subunits: 30 S (small subunit) and 50 S (large
subunit). The larger subunit consists of two species of rRNA (5 S and 23 S) and more
than 30 associated proteins. The small subunit consists of more than 20 associated
proteins and the 16 S rRNA that is approximately 1500 nucleotides long. The genes
encoding ribosomal RNAs are ancient. They are functionally constant, universally dis-
tributed and comprise of highly conserved sequence domains interspersed with more
variable regions (see Figure 4). The 16 S rRNA gene plays in the translational appara-
tus of the small subunit of the ribosome. This explains its high level of conservation
among bacteria. 16 S rRNA gene conservation among the domain Eubacteria is more
than 60% even among the most distantly related species [160]. In fact, the 16 S rRNA
gene has frequently been called a “molecular chronometer”, which reflects the evolu-
tionary distance between two bacteria over time. It has been most commonly employed
for identification purposes due to it’s optimal size. The sequence which encodes the
5 S subunit is too short and doesn’t provide enough information for species identifi-
cation. The 23 S rRNA gene also has conserved and variable regions and provides
possibly better phylogenetic resolution due to its increased length (3000 bp). How-
ever, application of 23 S rRNA gene for microbial community analysis is limited by lack
of established broad-range PCR amplification and sequencing primers [114]. “Broad-
range” PCR primers have been designed to recognize the conserved 16 S rRNA gene
sequences and used to amplify intervening variable or diagnostic regions without the
need to know any prior sequence or phylogenetic information about the unknown bac-
terial isolate [89, 167, 146]. The conserved regions are important for classification of
higher taxa, while the variable regions can be used for differentiation between closely
related species [137].
The first step in 16 S rRNA gene microbial community analysis is the DNA purifica-
tion. An important point is that this procedure must occur without introducing bias due
to e.g. differential lysis or recovery. All bacterial 16 S rRNA genes in the sample are
subsequently amplified using primers targeting generally conserved regions.
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Figure 4: Schematic structure of 16S rRNA gene
1.3.2 Terminal restriction fragment length polymorphism
For further characterization of amplified bacterial DNA fragments the terminal restric-
tion fragment length polymorphism (T-RFLP) analysis is considered to be the most ap-
propriate tool. T-RFLP analysis generates fragments that differ in length according to
the variation in the position of the first specific restriction endonuclease site in ribo-
somal sequences (see Figure 5). Msp I (C↓CGG
GGC↑C
), Hha I (G↓CGC
C↑GCG
), and Rsa I (GT↓AC
CA↑TG
) are used
most often since they were shown to resolve most often unique sequences in model
communities. It is important to note that for communities with more than 50 oper-
ational taxonomic units (OTUs), none of the restriction enzymes resolved more than
70% of the total OTUs in the communities with more than 50 operational taxonomic
units (OTUs). Thus T-RFLP can most efficiently be used for communities with low or
intermediate richness [145]. These fragments are typically fluorescently labeled and so
allow their detection on automated DNA sequencing machines. Generated fragments
are commonly species - specific in length and can be compared with existing (available
on the web) fragment libraries. ROGERS et al. stated using this method could identify
in cystic fibrosis patients besides such common bacteria such as P. aeruginosa and H.
influenzae also other species: P. oris, F. gonidoformans, B. fragilis, Leptotrichia-like sp.,
C. murliniae and S. ventriculi [132]. KAWANAMI et al. found in (BAL) samples of severe
pneumonia patients also E. faecalis, E. casseliflavus, V. parvula, V. atypica, V. dispar, L.
wadei and P. nanceiensis [87]. Both of these research teams also used sequencing as a
more advanced molecular approach.
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Figure 5: Terminal restriction fragment length polymorphism (T-RFLP) is a
method for providing semi-quantitative analysis of the diversity and dinam-
ics in microbial communities. In PCR amplification targeted fragment of
ribosomal RNA gene for the domain Eubacteria is amplified. The primer set
contains the fluorescent labels such as 6-carboxy-fluorescein (FAM) at the
5’ end of the forward primer. PCR products are then purified, concentrated
and completely digested with one or more endonucleases. Digested prod-
ucts are subjected to size separation with gel or capillary electrophoresis.
Each electrophoregram represents a fingerprint of the microbial commu-
nity. This method is indispensable in routine diagnostic because it allows
one to get the overview of present microbial community in short a time.
1.3.3 Sequencing
By means of sequencing it has become possible to determine nucleotide structure of
16 S rRNA genes, compare them with existing available online databases and thus iden-
tify new bacterial species associated with respiratory tract [2, 75]. The most popular
source in this field is the Basic Local Alignment Search Tool (BLAST): an algorithm
for comparing primary biological sequence information, such as the amino acid se-
quences of different proteins or the nucleotides of DNA sequences. A BLAST search
enables a researcher to compare a query sequence with a library or database of se-
quences, and identify library sequences that resemble the query sequence above a cer-
tain threshold (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Another web tool the riboso-
mal database project (RDP) provides bacterial and archaeal ribosome related data ser-
vices to the scientific community, including online data analysis, rRNA derived phylo-
genetic trees, and aligned and annotated rRNA sequences (http://rdp.cme.msu.edu/).
The Greengenes web application also provides access to the current and comprehensive
16 S rRNA gene sequence alignment for browsing, blasting, probing, and downloading
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(http://greengenes.lbl.gov/cgi-bin/nph-index.cgi).
Sanger-based sequencing (chain termination method) has dominated the molecular
biology landscape over the last three decades, primarily due to the desire of the inter-
national community to sequence the entire human genome. As a result, Sanger-based
sequencing was quickly adapted to a large-scale, high-throughput automation allowing
the parallel sequencing of DNA in up to 384 capillaries at a time. Over the last two
decades considerable resources were invested in the development of new alternative
sequencing strategies, and as recently as 2005 their utility was demonstrated. These
new sequencing strategies called next-generation DNA sequencing techniques provide
numerous advantages including high speed and throughput, full automation and ex-
pense reduction, and the determination of sequence data from amplified single DNA
fragments, negating the need of the in vitro cloning of DNA fragments [45]. These al-
ternative strategies for DNA sequencing can be grouped into several categories: micro-
electrophoretic methods, sequencing by hybridization, real-time observation of single
molecules and cyclic-array sequencing. They have recently been implemented in com-
mercial products: 454 pyrosequencing (used in the 454 Genome Sequencers, Roche
Applied Science; Basel) [9, 143], Solexa technology (used in the Illumina (San Diego)
Genome Analyzer), the SOLiD platform (Applied Biosystems; Foster City, CA, USA), the
Polonator (Dover/Harvard) and the HeliScope Single Molecule Sequencer technology
(Helicos; Cambridge, MA, USA). Excellent discussion and comparison of all basic prin-
ciples as well as devices can be found in review papers of SHENDURE and ANSORGE
[11, 156, 155]. As soon as such devices appeared on the market, the new specific appli-
cations have also become accessible [62]. For example, development of metagenomic
sequencing has led to the initiation of an international MetaHIT project, the main pur-
pose of which is to study human intestinal microbial metagenome [125, 25, 29, 49, 67].
This is the branch of the Human Microbiome Initiative with primary postulated goals
to determine if there is a core human microbiome, to understand the changes in the
human microbiome that can be correlated with human health, and to develop new
technological and bioinformatics tools to support these aims [184, 157]. To accelerate
new breakthrough in DNA sequencing technologies and to enhance methods of existing
analysis the READNA consortium was created. It includes 16 European partners from
both academia and industry. In 2008 they introduced the new method to identify bac-
teria [141]. It is based on the detection of patterns of protein masses by matrix-assisted
laser desorption/ionization (MALDI) mass spectrometry. The interdisciplinary nature
of the consortium will allow the exploration of novel concepts of nucleic acid analysis.
Further explosive development of the next-generation DNA sequencing and synthesis
techniques will enable improvement of a broad range of applications. CURRAN et al.
have evaluated the new diagnostic approach relevant for COPD patients using such a
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molecular-based tool as DNA microarray [43]. They described a novel respiratory mi-
croarray using PCR product probes for the detection of nine bacterial species in the
human respiratory tract. This technique could potentially be a useful method to moni-
tor the populations of bacteria in respiratory samples. Microarrays offer the advantage
of both unlimited target detection and simultaneous detection of organisms in clinical
specimens with complex microbiota [171]. HUANG et al. used in their recent work the
PhyloChip: DNA microarray for rapid profiling of microbial populations to study pul-
monary microbial communities of exacerbated COPD patients [79]. This high-density
microarray containing 500 000 probes can detect approximately 8500 bacterial taxa.
The analysis revealed the presence of over 1200 bacterial taxa representing 140 dis-
tinct families. A core community of 75 taxa was detected in all patients. In table 2
I have summarized the most common non-cultural approaches to studying pulmonary
microbial communities with some examples of supporting software and tools (see Table
2).
Generally, an optimal procedure for the identification of bacteria should comply with
the following criteria: provide a universal bacterial identification capability; identify all
bacteria in a sample quantitatively; detect emerging previously uncharacterized bac-
teria and find the most closely related species; make possible immediate and flexible
detection of bacterial samples, as well as high-throughput analysis; require low opera-
tional costs; process the transfer of information rapidly; and facilitate sharing of data
by establishing easily accessible and regularly updated databases [141, 140].
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Table 2: Molecular biology-based approaches.
Method Applications Programming tools
T-RFLP Whole picture of
microbial community,
semi-quantitative
GeneMapper — curve plotting
PCR, qPCR Targeted pathogen
identification;
quantitative
FastPCR — a free software for design
PCR primers;
GenEx software — qPCR data analysis
Microarrays Unlimited target
detection, simultaneous
identification
Cluster — hierarchical clustering,
self-organizing maps;
GeneXplorer — web-visualization of
microarray datasets;
MicroArray Suite — extracting and
visualizing DNA microarray data
Sequencing Identification of new
species
RDB and BLAST — sequence databases;
DOTUR — estimating species richness;
PHRED — sequence quality control;
Lusy — sequence quality trimming and
vector removal
Next-generation
sequencing
Identification of new
species and genes,
metagenomic studies,
comparative genomics,
gene regulation studies,
targeted resequencing,
DNA-protein
interactions
CLCbio Genomics Workbench — de novo
and reference assembly of Sanger
sequencing data;
RCluster — hierarchical clustering,
self-organizing maps;
GeneXplorer — web visualization of
microarray datasets;
MicroArray Suite — extracting and
visualizing DNA microarray data;
Illumina, Helicos, and SOLiD data Galaxy
— interactive and reproducible
genomics;
Genomatix — integrated solutions for
next Ggeneration sequencing data
analysis;
JMP Genomics —
visualization and statistics tool;
NextGENe — de novo and reference
assembly of Illumina, SOLiD and Roche
FLX data;
SeqMan Genome Analyser — next
generation sequence assembly of
Illumina, Roche FLX and Sanger data;
SHORE — for Short Read, is a mapping
and analysis pipeline for short DNA
sequences produced on a Illumina
Genome Analyzer
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2 Aims
The lower airways are constantly exposed to a broad variety of environmental microbes.
But there is a lack of information about bacterial diversity in the respiratory tract, be-
cause only classical culture techniques are steel used routineously in the diagnostic lab-
oratories. In this thesis it was dealt exclusively with pulmonary microbial communities
with a view to determine their compositional changes linked with COPD.
The aims of the study were:
1. To detect the most common respiratory pathogens by the PCR in sputum and
exhaled breath condensate samples of AECOPD patients
2. To test the suitability of culture independent molecular biology-based approach —
terminal restriction fragment length polymorphism (commonly used in environ-
mental microbiology) for processing of clinical samples
3. To characterise the pulmonary microbial communities presenting in the BAL sam-
ples of COPD patients and healthy individuals by sequencing
4. To provide more deeply knowledge about stable core microbiota of human lower
respiratory tract
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3 Materials and methods
Table 3: Chemicals used in work
Manufacturer Reagent
Carl Roth GmbH, Karlsruhe, Germany 0.5 mm zirconia beads
Agarose ultra
Ampicillin sodium salt
CASO boullion
Chloroform:isoamylalcohol 24:1
EDTA
Ethidium bromide
IPTG
LB agar medium
LB bouillon
Lysozyme
Na2HPO4·2H2O
NaCl
Nutrient broth
Paraformaldehide Phe-
nol:chloroform:isoamylalcohol
PIPES
Polyethylene glycol 6000
SDS
Sodium EDTA
Tris - HCl
Tween
Sigma-Aldrich GmbH, Munich, Germany Boric acid l
Fluorescein isothiocyanate
(FITC)
KCl
Methanol
RNase Inhibitor
Trisma® base
Water Molecular Biology
Reagent
X-gal
QIAGEN GmbH, Hilden, Germany Proteinase K
Roche Diagnostics, Mannheim, Germany Triton X-100
MERCK KGaA, Darmstadt, Germany CaCl2
NaH2PO4·H2O
Finnzymes Oy, Espoo, Finland DMSO
Mallinckrodt Baker Deutschland, Griesheim, Germany MgCl2·6H2O
PAA Laboratories GmbH, Pasching, Austria Dulbecco’s PBS
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3.1 Participant selection and sampling procedure
The study was approved by the ethics committee of the University of Marburg and
Saarland University; all participants gave written informed consent. There were two
groups: healthy people, who have never smoked, without immunosuppressive or other
life-threatening disorders and haven’t any respiratory illnesses for one year prior to the
study and COPD patients in a stable state (see Table 4). The diagnosis of COPD is today
based on lung function measurement. The qualitative parameter is bronchodilator ratio
of forced expiratory volume in 1 s (FEV1)/vital capacity (VC) or forced vital capacity
(FVC). If it is below 0.7 the COPD is diagnosed [98]. The mean value of FEV1/FVC
ratio was 0.576, C reactive protein (CRP) level in serum did not exceed 4.8mg/l and
the mean number of leukocytes was 8.0·109 cells/l. The patient was defined as stable if
there was no exacerbation for the previous 4 weeks and the patient was not currently
having an exacerbation.
Table 4: Participant characteristics
Parameter Lavage study AECOPD study
Healthy COPD
Age (yrs) 27±2.7 63±6.3 70.7±8.05
Sex, male (%) 55.6 55.6 18 (62.1)
Smokers/never-smokers, n 0 / 9 9 / 0 4 / 23 / 2
Pack years — 53.9±25.2 42.24±32.7
FEV1, % predicted — 50.2±14.4 39.35±11.35
FVC , % predicted — 57.6±15.74 54.54±15.38
Cells/ml, ·105 0.6 6.7 —
Leukocytes, ·109 /L — 8±1.89 11.93±4.85
Total DNA concentration in BAL, ng /µL 195.6 201.3 —
Bronchoscopy was performed by Prof. Dr. Dr. Bals and Dr. Rentz using a flexible
fiberoptic bronchoscope following mild sedation and local anesthesia with xylocaine
2%. Sterile isotonic saline was instilled into the bronchi in 10ml aliquots and collected
bronchoalveolar lavage fluid samples were immediately sent to the research laboratory.
Sputum and EBC samples from 29 patients (mean age 70 years, range from 52 to
83) with AECOPD were collected between December 2008 and April 2009 (see Table
4). AECOPD were defined in patients with known COPD presented with at least two of
the following symptoms (increased dyspnoea, increased sputum purulence, increased
sputum production) [64]. The study was approved by the ethics committee of the
University of Marburg and informed consent was obtained from all patients.
EBC was collected according to the published ERS guidelines [76]. In short, EBC
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samples were collected during 10min of quiet breathing through a single-use disposable
RTube™ collector (Respiratory Research, Inc., Charlottesville, USA), while subjects were
wearing a nose clip. The aluminum sleeve of the device had been cooled to an initial
temperature of −20 °C prior to collection. After collection, the plunger was used to pool
the condensed material within the tube into a single sample (about 1.0 ml). Samples
were stored in reaction tubes at a temperature of 4 °C. Immediately after EBC collection
patients proceeded to expectorated sputum sampling procedure. Sputa were collected
into sterile tubes applying a standard operation protocol. Each sputum and EBC sample
was divided into two equal parts used for the DNA and RNA isolation (approximately
500µl for each sample type). To prevent RNA degradation, EBCs were mixed with 10
volumes of RNAlaterTM RNA stabilization reagent (QIAGEN GmbH, Hilden, Germany).
3.2 Nucleic acid amplification tests
3.2.1 DNA purification
BAL samples were stored on ice prior to the DNA extraction. First lavages were cen-
trifuged by 2500 rpm at 4 °C for 10min. Then the supernatant was discarded and the
cell pellet was used as a starting material for the DNA isolation.
Total DNA was purified by using a combination of a bead-beating method with the
standard phenol:chloroform extraction. Each cell pellet was resuspended in 750µl
of sodium phosphate buffer and 250µl of TNS solution. Then 0.7 g of sterile zirco-
nium beads were added. After bead beating for 45 s at 6.5m/s (using the homogenizer
Precellys® 24, PEQLAB Biotechnologie GmbH, Erlangen, Germany), the samples were
put on ice. To sediment the remaining cells homogenates were centrifuged for 10min
at 4 °C. The supernatants were placed in 2ml vials on ice and the proteins were de-
naturated, with one volume of phenol:chloroform:isoamylalcohol solution. Following
the spinning down for 10min at 4 °C 800µl of supernatant were added to the equal
volume of chloroform:isoamylalcohol. After centrifugation under the same conditions
650µl of supernatant were mixed thoroughly with two volumes of PEG6000 and in-
verted 10 times. The extracted DNA was precipitated by spinning for 80min at 4 °C.
The liquid phase was removed by pipetting and 500µl of ice-cold 70% ethanol was
added to wash the the nucleic acid pellet. After the spinning down and removing the
ethanol the DNA was dried briefly at room temperature for 5min. Finally it was eluted
in 50µl of EB buffer and additionally incubated at 37 °C for two hours to enhance the
DNA recovery yield. Following each DNA isolation its concentration was determined
using NanoDrop™ 8000 (Thermo Fisher Scientific Inc., Wilmington, USA). As an addi-
tional step, we performed an overnight proteinaseK digestion prior to the extraction in
the case of sputum to lyse the mucous components.
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Table 5: Buffers and solutions used for the DNA extraction
Solution Composition Features
Sodium phosphate
buffer
112.87mM Na2HPO4
7.12mM NaH2PO4
pH=8, sterilize by filtering
or autoclaving
TNS solution 500mM Tris-HCl,
100mM NaCl, 10%
SDS (weight/volume)
pH=8, sterilize by filtering
or autoclaving
Phenol:chloroform:
isoamylalcohol
25:24:1 pH=7.5–8.0
Chloroform:
isoamylalcohol
24:1
PEG 6000 solution 30% (weight/volume)
polyethylene glycol
6 000 in 1.6M NaCl
prepare with RNAse free
water, sterilize by autoclaving
EB buffer 10mM Tris-HCl pH=8, prepare with RNAse
free water, sterilize by
filtering or autoclaving
As an additional step, an overnight proteinaseK treatment was performed prior to
the extraction to lyse the mucous components of sputum. DNA was extracted from
positive controls (M. catarrhalisMCCM 01214, L. pneumophilaDSM 7513, M. pneumo-
niaeATCC 29342 and C. pneumoniaVR-1360; and clinical isolates S. aureus, H. influen-
zae, S. pneumoniae) using the DNeasy© Blood & Tissue Kit (QIAGEN GmbH, Hilden,
Germany) according to the user’s manual. RNA was extracted using the NucleoSpin©
RNA L kit (Macherey-Nagel, GmbH, Düren, Germany) and its protocol for the total RNA
purification from cultured cells and tissue. Reverse transcription was performed using
the Fermentas cDNA synthesis kit (Fermentas, St. Leon-Rot. Germany). As positive
controls the RNA isolated from influenza viruses AH1, AH3 and respiratory syncytial
virus was used (kindly provided by Dr. Markus Eickmann, Institute for Virology, Philipps
University of Marburg). Nucleic acids isolated both from sputum and EBC specimens
were dissolved in a final volume of 50µl of elution buffer (10 mM Tris-HCl, pH=8.5
for DNA) or sterile RNase-free water (for RNA) and stored at −20 °C.
3.2.2 Polymerase chain reaction
Pure total DNA (100ng) was used as a starting material for the PCR-based amplification
of the 16 S rRNA gene. Used primer set generates a 900 bp long PCR product from E. coli
DH5α DNA. This enhances the accuracy rate in the sequence database search. The fol-
lowing oligonucleotides were obtained from Metabion GmbH (Martinsried, Germany):
forward primer Ba27f, 5’-AGA GTT TGA TCC TGG CTC AG-3’; reverse primer Ba907r, 5’-
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CCG TCA ATT CCT TTR AGT TT-3’. PCR mixtures were composed of 1 x PCR buffer, 2%
of DMSO, 0.2mM concentrations of each deoxinucleoside triphosphate, 0.5µM concen-
trations of each primer, and 1U of Phusion Hot Start DNA polymerase (Finnzymes Oy,
Espoo, Finland) in a final volume of 50µl. This polymerase has proofreading activity
and needs the heating procedure of 98 °C for 30 s to activate the enzyme. The samples
were subjected to the initial denaturation step of 94 °C for 3min and to 40 cycles of
denaturation at 94 °C for 30 s, annealing at 50 °C for 45 s, and extension at 72 °C for
1min and 30 s, followed by a final extension step at 72 °C for 7min. Amplification was
carried out by using a MyCycler Thermal Cycler (Bio-Rad, Munich, Germany). In each
amplification run the total E. coli DNA (100ng) was used as a positive control and 5µl
of Water Molecular Biology Reagent as a negative control. PCR products were stored at
−20 °C.
To detect typical pulmonary pathogens in sputum and EBC samples conventional
PCR approach with specific primer sets was used. Identified pathogens with corre-
sponding primers are listed in Table 6 [28, 73, 108, 173, 77, 154, 32]. All reactions
were performed in final volume of 25µl using Phusion DNA Polymerase (Finnzymes,
Inc., Espo, Finnland) in a Bio-Rad iCycler (Bio-Rad, Munich, Germany). The PCR con-
ditions are indicated in the references. A positive and a negative (water) control were
included with each PCR assay. All control PCR reactions were performed in separate 0.2
ml PCR tubes with flat caps (Fisher Scientific GmbH, Schwerte, Germany) to avoid any
possible contamination of clinical samples with control DNA.
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Table 6: Primer used for pathogen detection assays
Pathogen Forward primer (s) (5’-3’) Reverse primer (s) (5’-3’)
S. aureus CGC ATT GAT GGT GAT ACG
GTT
AGC CAA GCC TTG ACG AAC TAA
TGC
H. influenzae CTA CGC ATT TCA CCG CTA CAC CGT ATT ATC GGA AGA TGA AAG
TGC
M. catarrhalis CTA CGC ATT TCA CCG CTA CAC CCC ATA AGC CCT GAC GTT AC
S. pneumoniae CTA CGC ATT TCA CCG CTA CAC AAG GTG CAC TTG CAT CAC TAC C
L. pneumophila1 AAG AAT AGC CTG CGT CCG AT GTC AAC TTA TCG CGT TTG CT
GAG GGT TGA TAG GTT AAG AGC
M. pneumoniae AGG CTC AGG TCA ATC TGG
CGT GGA
GGA TCA AAC AGA TCG GTG ACT
GGG T
Influenza virus
AH12
CAG ATG CAG ACA CAA TAT GT
ATA GGC TAC CAT GCG AAC AA
AAA CCG GCA ATG GCT CCA AA
CTT AGT CCT GTA ACC ATC CT
Influenza virus
AH33
CAG ATT GAA GTG ACT AAT GC
AGC AAA GCT TTC AGC AAC TG
GTT TCT CTG GTA CAT TCC GC
GCT TCC ATT TGG AGT GAT GC
Respiratory
syncytial virus
GTC TTA CAG CCG TGA TTA GG
GAT GTT ACG GTG GGG AGT CT
GGG CTT TCT TTG GTT ACT TC
GTA CAC TGT AGT TAA TCA CA
C. pneumoniae GTT GTT CAT GAA GGC CTA CT GTG TCA TTC GCC AAG GTT AA
3.2.3 Agarose gel electrophoresis and purification of PCR products
The 1.5% (w/v) agarose gels prepared on tris-borate buffer (0.045M Tris-borate, 0.001
M EDTA, pH=8.0) were used to analyze PCR products. Addition of 0.01% of as inter-
calating agent such as ethidium bromide (v/v) allowed visualizing the DNA fragments
under the ultra violet light (Gel Doc™ 2000, Bio-Rad, Munich, Germany). Voltage
(E143, Consort nv, Turnhout, Belgium) of 5 V/cm (measured as the distence between
the electrodes) was applied to the gel tank (HU 13, Bio-Rad, Munich, Germany). Marker
DNAs (O’GeneRuler ™, Fermentas GmbH, St. Leon-Rot, Deutschland) were loaded into
slots on both the right and left sides of the gel and 6 x Orange DNA Loading Dye (Fer-
mentas GmbH, St. Leon-Rot, Germany) was mixed with each DNA sample prior to the
pipetting.
1Seminested PCR
2Nested PCR
3Nested PCR
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3.2.4 Terminal restriction fragment length polymorphism analysis
The terminal restriction fragment length polymorphism (T-RFLP) analysis was intro-
duced at the end of the 1990s [104]. The method involves restriction enzyme digestion
of PCR amplified 16 S rRNA gene. The PCR amplification entails fluorescent-labeled
forward primer, which allows detection of the digests by a DNA sequencer. Since the
locations of the restriction sites are not random, but have a phylogenetic background,
T-RFLP provides knowledge of the taxonomic position of the test bacteria [10, 31, 103]
(see Figure 6).
The T-RFLP analysis was performed using FAM (6-carboxyfluorescein)-marked PCR
products. For the PCR step the forward primer Ba27f (5’-AGA GTT TGA TCC TGG
CTC AG-3’) was labeled with FAM (Metabion GmbH, Martinsried, Germany). The
labeled PCR products were cut from the agarose gel and purified with a commercial
kit (NucleoSpin®Extract II, MACHEREY-NAGEL GmbH & Co. KG, Dueren, Germany)
and then subjected to restriction enzyme digestion. The reaction mixture composed of
120 ng of PCR product, 2.5U of restriction enzyme MspI (Promega GmbH, Mannheim,
Germany) 1µl of 10 x reaction buffer and 1µg of acetylated bovine serum albumine
(BSA) supplied by the same manufacturer. The final volume was adjusted to 10µl
with deionized sterile water. Following incubation for 3 h at 37 °C in the dark, sam-
ples were proceeded to the separation and detection of the digested products via cap-
illary electrophoresis on ABI 310 Genetic Analyzer (Applied Biosystems Deutschland
GmbH, Darmstadt, Germany) using the The GeneScan™ 500 ROX™ XL size standard
(Applied Biosystems Deutschland GmbH, Darmstadt, Germany). It is a ROX™ dye-
labeled size standard containing 16 ROX™ dye-labeled, single-stranded DNA fragments
suitable for the reproducible sizing of fragment analysis data. Generated data was anal-
ysed with GeneMapper® Software (Applied Biosystems Deutschland GmbH, Darmstadt,
Germany). For each sample the analysis was performed in duplicate.
25
Materials and methods
Figure 6: A control T-RFLP profile, generated by enzymatic digestion with
MspI of amplified 16S rRNA gene of H. parainfluenzae strain CIP 102513.
In the reference sequence obtained from the GenBank of the National Cen-
ter for Biotechnology Information the restriction site for MspI is marked
with a red box.
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3.2.5 Analysis of T-RFLP data
The electropherogram supplied with Excel table was obtained as output data after capil-
lary electrophoresis during T-RFLP analysis (see Figure 7). Electropherogram represents
the composition of microbial community. The x axis expresses the length in bp of cut
terminal fluorescently marked fragments and the y axis — the relative fluorescence in-
tensity of each fragment. The relative fluorescence intensity is the indirect degree of
particular fragment frequency in a given sample.
Figure 7: Electropherogram
Terminal restriction fragments between 50 bp and 700 bp were included in the anal-
ysis. Although the longer fragments can be measured as well by means of an extrapo-
lation option on the software, but it is connected with the loss of accuracy. Additionally
the lowest signal threshold of 50 relative units of fluorescence intensity was taken into
account. This prevented the recording of false peaks and background noise [55]. Tables
were extracted for each sample with peak size vs. fluorescence intensity and terminal
restriction fragments (TRFs) that differed by ±1 bp in different profiles were consid-
ered as identical in order to compare T-RFLP profiles between different samples. Final
T-RFLP analysis comprehends the comparison of terminal restriction fragments of dif-
ferent samples, in the first place the identification of unique and common peaks.
Microbial diversity was estimated with the Shannon-Wiener diversity index (H’) and
species richness value using the Excel software (Microsoft, USA). This index takes into
account both the number of species present and the proportion of the total accounted:
Hs=−
S∑
i = 1
pi log pi,
where S — the number of species and pi — the relative abundance of each species,
calculated as the proportion of individuals of a given species to the total number of
individuals in the community. It takes into account the number of phylotypes as well as
the evenness of band intensity on a gel. In contrast, the phylotype richness ignores the
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relative abundance of each phylotype and focuses only on the total number of unique
phylotypes in a particular community.
The relative abundance of each TRF within a given T-RFLP pattern was calculated
as the peak height of the respective TRF divided by the total peak height of all TRFs
detected within a fragment length range between 50 bp and 600 bp.
3.2.6 A-tailing procedure
Since the Phusion Hot Start DNA polymerase generates blunt-ended fragments PCR
products were modified using the A-tailing procedure. Volume of 5µl of purified PCR
fragment was mixed with 5U of SupraTherm™ Taq DNA polymerase (Ares Bioscience
GmbH, Cologne, Germany), 0.2mM concentrations of each deoxinucleoside triphos-
phate and 1µl of 10 x PCR reaction buffer containing 15mM MgCl2 (Ares Bioscience
GmbH, Colog ne, Germany). Deionized sterile water was added to a final volume of
10µl. The reaction mixture was than incubated at 70 °C for 30min. Using this method,
only one insert could be ligated into the vector (as opposed to multiple insertions that
can occur with blunt-ended cloning). In addition, with T-vector cloning there is no need
to dephosphorylate the vector, and there is a low background of religated vector.
3.2.7 Ligation
PCR amplification of DNA samples with universal eubacterial primer set resulted in
generating a mixture of 16 S rRNAgene amplicons belonging to different bacteria. This
enabled the determination of microbial composition of the sample using sequencing. To
separate the amplicons we performed the ligation reaction following the transformation
of competent E. coli DH5α with the obtained plasmid vector [91].
For cloning the pGEM®-T Easy Vector System obtained from Promega GmbH (Mann-
heim, Germany) was used (see Figure 8). Each poly (A)-tailed PCR product in a volume
of 2µl was mixed with 5µl 2 x rapid ligation buffer for T4 DNA Ligase, 1µl (corresponds
to 50 ng) of pGEM®-T Easy Vector and 1µl of T4 DNA Ligase (3 Weiss U/µl). The total
volume was adjusted to 10µl with deionized nuclease-free sterile water. Positive control
(provided in the kit insert DNA) as well as background control (without DNA insert) and
transformation control (0.1 ng of uncut plasmid DNA) were included. After mixing by
pippeting, the reactions were incubated overnight at 4 °C.
The appropriate amount of the PCR products to include in the ligation reaction was
calculated using the following equation:
ng of vector · kb size of insert
kb size of vector ·
vectormolar ratio
kb size of vector =ng of insert.
Since the insert:vector molar ratio 3:1 provides good results it was used in the calcula-
tions.
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Figure 8: pGEM ® -T Vector Map and Sequence Reference Points
50ng vector · 0.9 kb insert
3.0 kb vector ·
3
1 = 45ng of insert.
The pGEM®-T Easy Vector has been linearized at base 60 with EcoRV and a T added
to both 3’-ends. The EcoRV site will not be recovered upon ligation of the vector and
insert.
The pUC /M13 forward pUC /M13 reverse primers were used for sequencing of the
inserts. Using the universal eubacterial primer set would lead to the mismatches caused
by contamination of isolated plasmid DNA with chromosomal DNA of the host strain E.
coli DH5α.
3.2.8 Preparation of chemically ultra-competent E. coli cells
The given protocol is thoroughly described in the paper of INOUE et al. [82]. It is based
on slow growth, MnCl2-mediated competence and shock-freezing.
First one isolated colony of E. coli DH5α was picked from an over night LB agar
growth plate (37 °C) and incubated in 3 ml of LB bouillon. The next day cells were
grown at 37 °C and the optical density4 was measured at 578 nm (Ultrospec™2100
pro UV/Visible Spectrophotometer, GE Healthcare Europe GmbH, Munich, Germany) to
determine the cell concentration:
OD578nm · 10
9 = cells/ml.
Three individual flasks containing 400ml of autoclaved SOB medium (see Table 7) were
inoculated with 1·109, 2·109, and 4·109 E. coli DH5α cells.
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Table 7: Materials used for cloning
Name Composition Protocol
SOC medium 20g bacto-tryptone
5 g bacto-yeast extract
0.5 g NaCl
20mM glucose
1 L H2O
pH=7.0, adjust with 5N
NaOH;
sterilize by filtration throgh a
0.22-micron filter
SOB medium 20g bacto-tryptone
5 g yeast extract
8.55mM NaCl
2.5mM KCl
10mM MgCl2
1L H2O
pH=7.0, sterilize by
autoclaving
Transformation
buffer
10mM PIPES
15mM CaCl2
250mM KCl
55mM MnCl25
pH=6.7, sterilize by filtering
LB / ampicillin /
IPTG / X-Gal
plates
100mg /ml ampicillin stock
solution6
35g of LB agar medium
1L H2O
100mg /ml X-gal stock
solution7
100mM IPTG stock solution8
Cool down the autoclaved LB
agar medium to 55 °C, add
ampicillin stock solution to
the end concentration
100µg /ml, pour 25ml in a
10 cm dish.
After 48 hours of growth at 17 °C the OD578=0.4–0.6 was reached and the culture
was chilled for 10min on ice. The cells were pelleted at 2500 g (Heraeus Megafuge
1.0R, DJB Labcare Ltd, Buckinghamshire, England) at 4 °C. After this, the cells were
re-suspended in 100ml of ice-cold transformation buffer (see Table 7), incubated for
10min on ice and pelleted as above. Then 20ml of ice-cold transformation buffer and
7% (v/v) of DMSO were added and the suspension was incubated for additional 10min
on ice. It was extremely important not to exceed this time period, otherwise the survival
rate of cells would rapidly decline. Finally the cells were aliquoted into sterile 1.5ml
tubes and shock-frozen immediately in liquid nitrogen. Each aliquot (50µl) was stored
at −80 °C.
5The buffer was adjusted to near final volume and the pH was titrated prior addition of MgCl, since a
precipitate will be formed
6dissolved in sterile deionized water and stored at –20 °C
7dissolved in DMF and stored in the dark at –20 °C
8dissolved in deionized nuclease-free sterile water and stored at –20 °C
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3.2.9 Transformation using pGEM®-T Easy Vector
Tubes containing the ligation reactions were centrifuged shortly to sediment the con-
tents on the bottom of the tubes. Then 2µl of each reaction was transferred into a
1.5ml microcentrifuge tube (Biozym Biotech Trading GmbH, Hess. Oldendorf, Ger-
many) and put on ice. Highly competent E. coli DH5a aliquots were removed from the
−80 °C freezer and thawed on ice for 5min. Cells were mixed by gently flicking the
tubes and 50µl of each aliquot was carefully transferred into each tube with the lig-
ation reaction mixture. After gentle flicking, the tubes were placed on ice for 20min,
heat-shocked for 45 s in a water bath at exactly 42 °C without shaking and then returned
on ice for 2min. Next 200µl of room-temperature SOC medium was added to the tubes
containing cells transformed with ligation reactions and they were incubated for 1.5 hrs
at 37 °C with shaking (150 rpm). 25µl and 50µl of cell suspensions were plated on LB
agar plates containing ampicillin, IPTG and X-Gal, and incubated overnight (16 h to 24 h)
at 37 °C. The next day transformation efficiency was evaluated using the following ini-
tial data: 50µl of competent cells were mixed with 0.1 ng of uncut plasmid DNA and
dissolved in 200µl of SOC medium. Thus the concentration of plasmid vector DNA was:
0.1ng · 1ml/0.25ml = 0.025ng/ml.
Transformation efficiency:
178CFU
0.000625ng
= 2.8 · 105CFU/ng = 2.8 · 108CFU/µg DNA.
Recombinant clones were identified by blue-white screening because successful cloning
of an insert into the pGEM®-T Easy Vector interrupts the coding sequence of β-galactosida-
se.
3.3 Phylogenetic tree construction
Obtained sequences were assembled into a consensus sequence using the DNA sequence
analysis software Ugene (Unipro Novosibirsk, Russia). For sequence alignment analysis,
approximately 900 bps of the sequence (5’–3’, with primer ends) were compared with
those available in the GenBank of the National Center for Biotechnology Information by
BLAST search. Identification of the species level was defined as at least 98% similarity
of the 16 S rRNA gene sequence to the sequence of its closest bacterial relative in the
GenBank database using online software BlastN (National Center for Biotechnology In-
formation ( NCBI), USA). The multiple alignment analysis was performed using Ugene.
Multiple sequence alignment algorithms insert gaps in order to align the sequences to
maximize similarity according to the evolutionary model summarized in the substitu-
tion matrix. Gaps correspond to an insertion or deletion of a substring (sometimes a
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single residue). Gaps can occur because of single mutations, DNA slippage. The “gap
open cost” is the error of introducing gaps in an alignment and the “gap extension cost”
is the error of every extension past the initial gap. Varying the “gap open” and “gap
extension” costs not only produces very different alignments but produces different dis-
tributions of phylogeny scores [138]. We used such gap settings: gap open cost — 10,
gap extension cost — 1, end gap cost — as any other. Gaps and regions of alignments
for which homology of residues could not be reasonably assumed were excluded from
the phylogenetic analysis. The construction of phylogenetic trees is closely related to
that of multiple alignments. Some progressive alignment techniques even use a phylo-
genetic tree to determine the order of the progressive adding of sequences [17]. The
neighbor-joining tree was constructed using Ugene and uploaded to the Interactive Tree
of Life project (http://itol.embl.de/) for annotation [102]. Bootstrapping was carried
out 1 000 times to evaluate the tree statistically.
3.3.1 Sequence analysis
The Sequin program (http://www.ncbi.nlm.nih.gov/projects/Sequin/) was used to sub-
mit the sequences to the GenBank® database. Chimeras (DNA sequences composed
of DNA from two or more parents: artifacts made during the PCR process [53]) and
vector sequence fragments were removed using the Black Box Chimera Check (B2C2)
software ( http://www.researchandtesting.com/B2C2 ) and the Vector Screening tool
(RunVecScreen, Sequin) respectively [66]. The method of chimeric sequences exclu-
sion extracts 100 bp long contiguous start and end regions of each FASTA format input
sequence. These regions are then aligned against a custom BLAST database contain-
ing 7 199 high quality sequences consisting of a representative, verified set of bacteria
with full taxonomic information (at all 7 major levels). Each species of bacteria was
only included once to minimize search space. When sequences are aligned against this
database, taxonomic information of each of the regions is evaluated and the percent-
age of matching taxonomic levels is calculated from species back to the kingdom level.
The higher the taxonomic identity between both regions, the less likely it is that the
sequence is chimeric [66]. The parameters of search were as follows: region of analysis
— ends, number of base pairs to analyze — 100, minimal sequence length to be con-
sidered — 100, lower threshold — 4, upper threshold — 6. The short sequences and
“Definite Chimeras” were removed.
3.3.2 OTUs definition
The phylogenetic tree was constructed using distance neighbor-joining method (Phylip
package). of phylogenetic analysis. A basic concept of neighbor-joining method is the
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concept of “neighbors”. The distances are assumed to be additive, meaning that the
pairwise distance between two organisms can be achieved by adding the distances of
each branch in the tree. A pair of operational taxonomic units (or aligned sequences)
are neighbors if they are connected by a node. Operational taxonomic unit (OTU) — is
just that: a defined level which taxonomists use to discuss or compare organisms, the
terminal level at which that taxonomy classifies the sequences. While it might be all
the way down to the specific strain for one taxonomy it might only be to sub-order for
another (http://greengenes.lbl.gov/cgi-bin/nph-index.cgi). Although the OTU cut-off
depends on the diversity of a particular microbial community, it is considered that OTUs
that are defined by distances of less than 0.03 correspond to a strain-level delineation,
of 0.03 correspond to a species, of 0.05 correspond to a genus, of 0.15 correspond
to a class, and of 0.20 to 0.30 correspond to a phylum [144, 119]. To determine the
distances between aligned sequences the distance matrix view was used (Unipro Ugene,
Novosibirsk, Russia).
3.4 Fluorescence in situ hybridization
The in situ detection of nucleic acid sequences (genes on chromosomes, mRNA in tis-
sues) provides a direct visualization of the spatial location of specific sequences. The in
situ hybridization takes advantage of the specific annealing of complementary nucleic
acid molecules (DNA or RNA) through hydrogen bonds formed between bases attached
to the sugar phosphate backbone. This base pairing underlies the formation of a dou-
ble stranded-complex, in which one strand has opposite orientation to the other with
respect to the sugar phosphate backbone. The sequence is read from 5’ to 3’ (this refers
to the position of the sugar at which the phosphate residues are attached). Any nucleic
acid sequence can therefore be specifically detected by use of a probe that is the “anti-
sense” reverse complementary sequence [178, 30]. At the end of the 1990s AMANN et
al. had optimized this method for the identification of bacteria in polymicrobial com-
munities [8].
FISH was performed on human and mice lung tissue sections. In order to preserve
the cell and tissue structure, specimens were fixed with formaldehyde for 12 h at 4 °C.
Freshly prepared 4% (w/vol) paraformaldehyd solution in 0.1M phosphate buffered
saline (pH=7.2) was used as a fixative agent. SM 2000R sliding microtome (Leica
Mikrosysteme Vertrieb GmbH, Wetzlar, Germany) was used to prepare the microsec-
tions. 1µm to 2µm paraffin sections were collected on bio-adhesive coated SuperFrost
PLUS® glass slides (VWR International GmbH, Darmstadt, Germany). Prior to FISH,
slides were dewaxed: xylene — 20min, xylene — 10min, 100% ethanol — 5min,
100% ethanol — 5min, 96% ethanol — 5min and 70% ethanol — 5min.
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In order to detect the general bacterial colonization in lower airways, the universal
eubacterial oligonucleotide probe EUB338 (5’-GCT GCC TCC CGT AGT AGG AGT-3’) was
used. This probe is complementary to a region of the 16 S rRNA gene. The 5’ end of the
probe EUB 338 was labeled with the fluorophore Alexa 647 (absorption 650 nm, emis-
sion 668nm; Invitrogen GmbH, Darmstadt, Germany). The labeled probe was commer-
cially purchased from IBA GmbH, Goettingen, Germany. The NONEUB338 probe with
the same 5’ end labeling (5’-CGA CGG AGG GCA TCC TCA-3’), which is complementary
to the EUB338, was used as a negative control. Pure culture of S. aureus, resuspended
in 20µl of sterile water and fixed on a glass slide, was used as a positive control.
To facilitate the penetration of the probe for the gram-positive bacteria, the slides
were incubated in 25µl of freshly prepared, pre-warmed lysozyme work solution (20
mg/ml) at 37 °C for 10 min in a humid chamber. Lysozyme work solution contained
2mM of sodium EDTA, 1.2% (vol/vol) of Triton X-100 and 20mM of Tris-HCl (pH=8.0).
After the incubation slides were rinsed in distilled H2O and air dried.
The glass slides were than exposed to 20µl of hybridization buffer, containing 100ng
of the oligonucleotide probe and incubated at 46 °C for 36 hs in a humid atmosphere in
the dark. Then the slides were covered with cover glasses and put into 50ml polyethy-
lene tubes (SARSTEDT AG & Co., Nuembrecht, Germany). The humidity conditions
were reached by putting pieces of blotting paper into a polyethylene tubes and soaking
them with the remaining hybridization buffer.
Table 8: Hybridization buffer.
Stock reagent Volume, µl Final concentration
5M NaCl 360 900mM
1M Tris-HCl 40 20mM
10% SDS (added last to avoid
precipitation)
2 0.01%
Formamide 400 20%
RNase inhibitor 333 of 1:5
concentrate
—
dH2O add to 2ml (870) —
The stability of hybrids depends on the temperature, the monovalent cation concen-
tration, the percentage of C - G bases and the hybrid size. The melting temperature (Tm)
is the temperature at which 50% of the two DNA strands are denatured [46]. For a
hybrid size of less than 200 base pairs, the Tm follows the next equation:
Tm = 85.1 °C + 16.6 · log [Na+] + 0.41(% G − C) − 820 /L− 0.65 · (% F ),
where Na+ is the ionic concentration (in moles per liter) of sodium salt, L — the size
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of the probe in base pairs and F — the percentage of formamide in the hybiridization
buffer. Thus:
TmEUB338 = 81.5 + 16.6 · log 5 + (0.41 · 62) − 820 / 21 − 0.65 · 20 = 79 °C.
The hybridization experiments are usually performed at (Tm−20 °C), but the adding of
formamide allowed us to lower the hybridization temperature to 46 °C.
Table 9: Washing buffer for FISH
Stock reagent Volume, µl Final concentration
5M NaCl 225 225mM
1M Tris-HCl 1000 20mM
10% SDS (added last to avoid
precipitation)
50 0.01%
0.5M EDTA 500 5mM
dH2O add to 50ml
After hybridization the slides were quickly transferred into a preheated washing
buffer and incubated for 15min at 48 °C in a water bath (Köttermann GmbH & Co
KG, Uetze/Haenigsen, Germany), rinsed with dH2O for several seconds, air dried and
embedded in Antifade/DAPI (absorption 358 nm, emission 461 nm) mounting medium
(AppliChem GmbH, Darmstadt, Germany). The glass slides with the stained sam-
ples were examined on a fluorescence research microscope Olympus BX 53® (Olympus
America Inc., Melville, New York, USA) using cellSens® software control.
3.5 Statistical analysis
Although the analysis of T-RFLP data has developed considerably over the last decade,
there remains a lack of consensus about which statistical analyses offer the best means
for finding trends in this data. There are several common statistical approaches de-
scribed in the literature: principal component analysis (PCA), correspondence analysis,
detrended correspondence analysis, and the additive main effects and multiplicative in-
teraction model [42]. T-RFLP results obtained in this study were analyzed using PCA.
PCA is a projection method that helps visualize the main information contained in large
data tables. PCA involves a mathematical procedure that transforms a number of possi-
bly correlated variables (genera detected in microbial communities of different origins)
into a smaller number of uncorrelated variables called principal components. The first
principal component accounts for as much of the variability in the data as possible,
and each succeeding component accounts for as much of the remaining variability as
possible. The result is a new set of variables that represent linear combinations of the
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original variables that are uncorrelated and reflect the most important structure of the
data. Values for each sample projected onto these “loadings” are then calculated and
called “scores”. The PCA analysis was performed by J. Pauling (Max-Planck-Institute for
Informatics, Saarbruecken).
All cell culture experiments were performed in triplicate. Nonparametric unpaired
two-tailed T-test with confidence interval 95% was carried out to evaluate statistically
the obtained data.
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A total of 29 patients with AECOPD were recruited to study. Ten most common respira-
tory pathogens were detected by PCR. Both EBSs and sputa were tested on the presence
of any of them. To study the bacterial communities more deeply and to determine if
there are compositional changes in pulmonary microbiota linked with COPD 18 BAL of
adult subjects were studied. This consisted of two groups: 9 healthy individuals and 9
COPD patients.
4.1 Bacterial DNA is present in BAL
As mentioned in Table 4, the average total DNA concentration isolated from BAL sam-
ples was 200 ng/µl. The major part of it is composed of nucleic and metahondrial eu-
karyotic DNA. Therefore, not knowing the exact amount of target bacterial DNA I first
optimized the PCR conditions. After 40 cycles of amplification all the samples showed
positive results viewed bands in the agarose gel (see Figure 9).
Figure 9: Agarose gel electrophoresis of amplified 16S rRNA gene frag-
ments. Total DNA extracted from the cell pellets of BAL samples was used
as a starting material for the PCR (left). In each ampligication run the to-
tal E. coli DNA (100ng) was used as a positive control and 5µl of Water
Molecular Biology Reagent as a negative control. After 40 cycles of ampli-
fication distinguishable bands were visible under the ultra-violet light. The
amplificates were cut out of the gel, cleaned up and cloned into E. coli host
cells. To check if the cloning procedure was successful isolated plasmid
DNA was amplified with M13 universal primer set (right). The possible
contamination of the plasmid DNA with the genomic DNA of E. coli has
made the use of primers specific for the 16 S rRNA gene undesirable.
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4.2 Pathogens in sputum and exhaled breath condensate
A total of 29 patients with AECOPD were recruited during a four month study period
(December 2008 – April 2009). Both exhaled breath condensates and sputum were
analysed for each of the 10 pathogens. Patients with ID numbers 1, 2, 4, 7, 8, 13,
16, 19, 20, and 28 received antibiotic treatment (see Figure 12). Antibiotics included
quinolones, third-generation cephalosporins, macrolides and β-lactams.
Firstly, I analyzed whether NA can be extracted from EBC. DNA and RNA concen-
trations were determined in both sample types directly after the isolation procedure.
DNA could be detected in all sputa and about 90% of EBCs (25 probes). RNA could be
extracted from 84% of sputa and from 72% of EBCs (24 and 21 probes respectively)
(Figure 10). Other samples revealed no detectable RNA or DNA. While the amount
of RNA was equivalent for sputum and EBC, substantially more DNA could be isolated
from sputum.
The next step was to determine whether species-specific PCR can be sucsessfully per-
formed on EBC samples. Different bacteria and viruses were identified in both sample
types. About 80% of the sputa were positive, whereas 50% of EBCs revealed a positive
result. Figure 11 summarizes the results for all detected microorganisms.
One critical issue is whether EBC and sputum samples reveal similar results. Figure
12 displays the distribution of the positive results in individual patients. Surprisingly,
the data obtained from both materials did not correlate well. Only one patient had S.
aureus simultaneously in both samples. C. pneumoniae was not found in the studied
patient group. Six individuals had negative results in EBC and sputum. Remarkably,
influenzaAH3 virus presence was always associated with bacterial infection (in most
cases S. aureus). Detection of S. pneumonia was associated with the presence of S.
aureus in almost all cases. Viruses were identified in sputum samples of patients with
antibiotic administration. Some condensates showed primarily the presence of S. aureus
DNA in these patients. All sputa (except patient with ID 19) of such patients were
bacteria-negative.
Co-infection is a common phenomenon in AECOPD. The presence of multiple patho
gens was detected in 18 of the 29 patients (62%) when taking the results of both EBC
and sputum analysis into account. Figure 12 shows the distribution of the number of
detected pathogens. M. catarrhalis, H. influenza, andM. pneumoniae could be identified
only in the presence of other pathogens. Eight subjects revealed both bacteria and
viruses in their samples. No correlation was found between the number of individual
pathogens and clinical severity, CRP, leukocytes, or FEV1 (data not shown).
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Figure 10: DNA (a) and RNA (b) concentrations in exhaled breath con-
densate (EBC) and sputum samples. No significant difference was detected
between RNA concentrations in the two studied sample types (A). Signif-
icantly more DNA was isolated from sputum as compared with EBC (B).
Ten control condensates (HC EBC) collected from healthy individuals were
included. *** indicates p < 0.0001.
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Figure 11: Bacterial and viral nucleic acids can be detected by PCR. PCR
was performed on the nucleic acids isolated from sputum (black) and ex-
haled breath condensate (EBC) (white). Differences between both ma-
terials were analysed by χ2-squared test with Yate’s correction: P (RSV)
= 0.4718, influenza virus AH1 = 0.2357, influenza virus AH3 = 0.0002,
Haemophilus influenzae= 0.6043,Moraxella catarrhalis = 0.6664, Staphy-
lococcus aureus = 0.3781, Streptococcus pneumoniae = 0.0613, Legionella
pneumophila = 0.4718, Mycoplasma pneumoniae = 0.4718, and for the
samples without pathogen detection = 0.1073.
positive exhaled breath condensate samples positive sputum samples pathogens detected in both sample types
Figure 12: Distribution of positive sputum or EBC results in individual
patients. Only S. aureus was detected in both sputum and EBC in one
patient.
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Figure 13: Microbes identified in sputum samples of exacerbated COPD
patients using a conventional PCR set with specific primers (a). Exacerba-
tion status is linked to acute infection (viral or bacterial, and in rare cases
fungal). Common pulmonary pathogens were detected only in about 72%
of examined samples. Influenza virus AH1, S. aureus and S. pneumoniae
appeared to be the most common exacerbative agents. 31% of patients had
mixed infections with 2, 3, or even 5 pathogens detected simultaneously
(b).
COPD patients who have potentially pathogenic microorganisms in their sputum
show an exaggerated airway inflammatory response and poorer health status [20].
4.3 T-RFLP is a suitable tool to study pulmonary microbiota
T-RFLP analysis of obtained 18 BAL samples from healthy individuals and COPD pa-
tients included the comparison of terminal restriction fragments with RDP database
((R10. U26) 703 222 Good Quality (>1200) Bacterial). This comparison resulted in
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phylogenetic assignment of fragments and was performed using a web-based tool Mi-
crobial Community analysis III (MiCA3) with the following parameters: T-RFLP analysis
(PAT+), digest sensitivity — 2 mismatches within 2 bases from 5’ of forward primer,
window size — forward match ±1 bp.
Some fragments could not be matched and assigned because of some gaps in the
database. If no appropriate match was found in the database the fragment was marked
as “\-”. Some fragments were identified as “uncultured bacteria”. They could also not
be phylogenetically assigned.
Fluorescence intensity reflects the relative abundance of particular bacterium in the
sample. But it is important to note that abundance is calculated on the basis of 16 S
rRNA gene copies. This parameter has high diversity amongst the species and does
not correspond necessarily to a number of bacterial cells. All terminal fragments were
classified as “of the most frequent occurrence ribotypes” if the relative fluorescence of
peaks was >3%.
4.3.1 Bacteria in healthy individual BAL samples
As example, Figure 14 illustrates the bacterial community detected in the healthy person
with ID number 5. All terminal restriction fragment (TRF) profiles represent the ribo-
types of frequent occurrence. Prevotella, Bacteroides and S. umbrinus NRRL B - 2572T
(96bp, 205 bp and 234 bp respectively) were found more frequently in ID number 5
sample (see Figure 14). Potentially pathogenic genera as Pseudomonas andMycoplasma
were also present. Two distinct representatives of the genus Lactobacillus composed
2.6% of total microbial community.
Figure 14: T-RFLP profile obtained from healthy individual with ID num-
ber 5. Peaks with size 17 bp, 24 bp and 34bp were excluded from the
analysis. Species richness - 15. \- (53 bp) - affiliation of the fragment could
not be deduced.
In ID the number 6 sample (see Figure 15) the genera Prevotella and Veillonella
dominated. Prevotella was one of the most common bacteria also in ID number 7 and 9
samples. Interestingly in this sample uncultured Legionella sp. (498 bp) was also found.
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It composed almost 2% of the community. Clones of Actinomyces and Megasphaera
appended the species richness. S. pneumoniae (552 bp) with 9% of relative abundance
was the third major ribotype.
Figure 15: T-RFLP profile obtained from healthy individual with ID num-
ber 6. Peaks with size 17 bp, 24 bp and 34bp were excluded from the
analysis. Species richness - 19. \- (53 bp) - affiliation of the fragment could
not be deduced.
In Table 10 I summarized T-RFLP analysis results obtained in the healthy individual
group. They illustrate bacterial genera distribution between different individuals. No
common pattern of species distribution could be defined. All studied samples showed
highly heterogeneous patterns. Some bacterial genera, such as Bacteroidetes, Lactobacil-
lus, Megasphaera, Prevotella and Streptomyces were most common and appeared in two
thirds of studied samples. In contrast, Actinomyces, Bacillus, Corynebacterium, Lactococ-
cus, Micrococcus, Peptostreptoocccus and some other genera could be found only in cer-
tain individuals. Interestingly, the presence of genus Lactobacillus completely correlated
with distribution ofMegasphaera between the individuals and partly with occurrence of
Mezorhizobium, Pseudomonas and Streptomyces. But representatives of Lachnospiraceae
in samples with ID numbers 1 and 2 (see Table 10) were found simultaneously with
genus Xanthomonas.
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Table 10: Terminal restriction profiles in healthy individual samples
Potential representative ID1 ID2 ID3 ID4 ID5 ID6 ID7 ID8 ID9
\- (no match was found) + + + + +
Acinetobacter + + +
Actinomyces +
Bacillus +
Bacteroidetes + + + + + + + +
Clostridiales + + + + +
Corynebacterium +
Firmicutes oral clone + + +
Flavobacterium + +
Fusobacterium + + +
Lachnospiraceae + +
Lactobacillus + + + + + +
Lactococcus +
Legionella + +
Megasphaera + + + + + +
Mesorhizobium + + + + +
Microbacteriaceae +
Micrococcus +
Mycoplasma + + + +
Neisseria + + +
Peptostreptococcus +
Porphyromonadaceae + +
Prevotella + + + + + +
Pseudomonas + + + + +
Ralstonia + + +
Rhizobium +
Selenomonas +
Sphingomonadales + + + + + +
Staphylococcus +
Stenotrophomonas +
Streptococcus + + + + +
Streptomyces + + + + + + +
uncultured bacteria + + + + + +
Veillonellaceae + + + +
Xanthomonas + +
4.3.2 Molecular fingerprint analysis of COPD patient BAL samples
Figure 16 shows relative abundance of ribotypes detected in COPD patient with ID num-
ber 1. X. campestris EGS09 (411 bp) and Sphingomonas sp. SaS3 (436 bp) dominated
in this patient making up 17% and 19% of total community respectively. Oral clones of
Actinomyces and some Firmicutes bacterium were also presented in total relative abun-
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dance of about 14%. Potential pathogen C. glutamicum ATCC27021 made up 3.5% of
microbial community.
Figure 16: T-RFLP profile obtained from COPD patient with ID number 1.
Species richness - 17. \- (357bp) - affiliation of the fragment could not be
deduced.
Low biodiversity was characteristic for the sample of COPD patient with ID number
4 (see Figure 17). The most dominant ribotype appeared to be Sphingobacterium sp.
Bmc112 (550 bp) with relative abundance of 68%. That was also significant for that
sample as only a single pathogenic genus Pseudomonas (482 bp) was detected. Prevotella
(96bp), Lactobacillus (179 bp) and Clostridiales (204 bp) ribotypes were rare (<1%).
Figure 17: T-RFLP profile obtained from COPD patient with ID number 4.
Peaks with size 14bp, 23 bp and 690bp were excluded from the analysis.
Species richness - 9.
Some ribotypes (Bacteroidales, Clostridiaceae, Lactobacillus, and Prevotella) were
present in almost all studied samples, while Actinomyces, Alkaliphilus, Gemella, Le-
gionella, Neisseria sp., Peptostreptococcus, Selenomonas, Streptobacillus, and Treponema
detection characterized only particular patients (Table 11). No pattern, which could be
linked to the COPD state, was found. But presence of Lactobacillus correlated mostly
with detection of Bacteroidales. Genera Mycoplasma (6 positive samples), Pseudomonas
(5 positive samples) and Staphylococcus (5 positive samples) as potential pathogens
seem to play the major role in the persistent chronic infection in COPD patients.
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In order to compare the community structure, the species richness and Shannon
diversity index were calculated for two sample groups. No difference between COPD
patients and healthy individuals could be seen (Figure 18).
Thus, T-RFLP analysis showed highly diverse composition of pulmonary microbial
communities in healthy individuals as well as in COPD patients.
(a) (b)
i
Figure 18: Species richness (a) and diversity index (b). Terminal restric-
tion fragments shorter than 50bp were excluded from the analysis. Empty
squares correspond to healthy individuals, filled squares — to COPD pa-
tients.
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Table 11: Terminal restriction profiles in COPD patient samples
Potential representative ID1 ID2 ID3 ID4 ID5 ID6 ID7 ID8 ID9
\- (no match was found) + + +
Acinetobacter + +
Actinomyces +
Alkaliphilus +
Bacillus + + + + + +
Bacteroidales + + + + + + + +
Clostridiaceae + + + + + + +
Corynebacterium + + + +
Firmicutes oral clone + + + + +
Flavobacterium + +
Fusobacterium + + + + +
Gemella +
Lachnospiraceae + +
Lactobacillus + + + + + + +
Legionella +
Lysinibacillus + +
Megasphaera + + +
Mycobacterium +
Mycoplasma + + + + + +
Neisseria sp. +
Peptostreptococcus +
Porphyromonadaceae + +
Prevotella + + + + + + +
Pseudomonas + + + + +
Ralstonia + +
Selenomonas +
Sphingomonas + + + +
Staphylococcus + + + + +
Streptobacillus +
Streptococcus + + + +
Streptomyces + + +
Treponema +
uncultured bacteria + + + + + + + + +
Veillonella + + + +
Xanthomonas + +
4.4 Sequencing data
Altogether about 800 sequences were included in the analyses. Gaps and regions of
alignments for which homology of residues could not be reasonably assumed were
excluded. An average of at least 880 nucleotides were included in the phylogenetic
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analysis of eubacterial clones.
Most of the respiratory bacterial sequences had a relatively high level of similarity
with their closest counterparts found in public databases (the mean similarity of 96.3%
with the cultured bacteria). The phylogenetic relationships of bacterial sequences were
analyzed with 151 phylotypes and closely related reference sequences obtained from
the GenBank database.
(a) (b)
Fusobacteria Bacteroidetes
Actinobacteria Actinobacteria
Fusobacteria
Cyanobacteria
Bacteroidetes
Firmicutes ProteobacteriaFirmicutes Proteobacteria
Figure 19: Relative distribution of identified phyla in healthy individuals
(A) and COPD patients (B).
Most of the sequences matched in the database with phyla Firmicutes and Proteobac-
teria (Figure 19), which composed 40 and 35% in healthy individuals, and 35 and
45% — in COPD patients respectively. Other bacteria belonged to Fusobacteria, Bac-
teroidetes, and Actinobacteria. The phylum Cyanobacteria was characteristic only for the
COPD patient group.
(a) (b)
Aerotolerant
Aerobic 40 %
Anaerobic 40 %
Aerotolerant
20 % 21 %
Aerobic 45 %
Anaerobic 34 %
Figure 20: Relation to the oxygen. (a) — healthy individuals, (b) — COPD
patients.
Interestingly, anaerobic representative of standard microbiota made up 40% of the
total community in the healthy individuals, and about 34% in the COPD patients (see
Figure 20). Almost 20% of identified bacteria could tolerate the oxygen in both sample
types.
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Gram-positive
69 %
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31 %
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70 %
Gram-negative
30 %
Figure 21: Cell wall composition. (a) — healthy individuals, (b) — COPD
patients.
Gram-negative bacteria cause infections in the respiratory tract most often. Our
results showed that one third of bacterial representatives had such a type of cell wall
(Figure 21).
4.4.1 Phylogenetic tree evaluation
The phylogenetic trees were constructed using the clustering neighbor-joining method.
After construction, the reliability of trees was estimated by nonparametric bootstrap-
ping. Bootstrapping is a statistical technique that tests the sampling errors by repeatedly
sampling trees through slightly perturbed datasets [183]. By doing so, the robustness
of the original tree could be assessed. All the bootstrapped trees are summarized into a
consensus tree based on a majority rule. It is considered, that a bootstrap value of 70%
approximately corresponds to 95% statistical confidence.
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Figure 22: Phylogenetic tree ilustrating the standard microbiota present in
healthy lungs. Different genera are denoted with different colors with one
exception: the family Sphingomonadaceae represents the taxon of higher
rank. Bacteria marked with green circles were detected only in healthy
individuals, but not in COPD patients.
This dendrogram (see Figure 22) represents the phylogenetic relationships of ana-
lyzed bacterial sequences and therefore shows that genera Prevotella, Streptococcus and
Acinetobacter were more diverse, representing multiple species and strains. Despite the
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fact that Rhizobium radiobacter infection has been associated with long-term indwelling
catheters, and several cases have also been reported in immunocompromised individu-
als, three representatives of this genus were detected in healthy individuals only. This
genus was present also in respiratory secretions of CF patients [39]. There are no known
interactions of the nearest relative of Rhizobium sp. Mesorhizobium loti with humans or
animals. But in our study it was found that nitrogen-fixing M. loti was characteristic
for the healthy state. H. parainfluenzae, Kartchner Caverns bacterium, P. acnes, M. lu-
teus, Terrahaemophilus sp., E. saburreum, Selenomonas sp., S. periodontii, and L. sakei
made up 24% of the total microbial community and were also present only in healthy
individual group samples. Nonsporeforming, Gram-positive, anaerobic bacterium P. ac-
nes is found all over the body and generally produce lactic acid, propionic acid, and
acetic acid from glucose. Similarly, M. luteus has been previously isolated from human
skin. The defining metabolical characteristics of Micrococcus are the abilities to aerobi-
cally produce acid from glucose glycerol, aesculin hydrolysis, arginine dihydrolase, and
conversion of nitrate to nitrite.
One difference between T-RFLP analysis and sequencing results cannot be ignored:
lactic acid bacteria of genus Lactobacillus was found in both sample types using the T-
RFLP approach, whereas its detection was successful only in healthy volunteers samples
when the clone sequencing was applied.
A second distance-based neighbor-joining tree was constructed with 76 phylotypes
(Figure 23). 29 distinct phylotypes were detected in the studied cohort of patients. Gen-
era Streptococcus, Veillonella and Prevotella were most common and had the highest di-
versity. The diagram depicts that there were more than 20 unique ribotypes (composing
36.8% of total community) characteristic of the COPD state. For example, Gemella sp.
— Gram-positive, facultatively anaerobic bacteria, which have been previously found to
be involved in pulmonary exacerbations of cystic fibrosis patients.
A common microbial community of 9 bacterial genera was identified in all samples
analyzed. This core group included members of the Prevotella, Sphingomonadaceae,
Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veillonella, Staphylococcus,
and Streptococcus. The sequencing data was also examined for the presence of the atyp-
ical bacteria, M. pneumoniae, L. pneumophila, and C. pneumoniae, which are associated
with COPD exacerbations. None were detected by this method, although Mycoplasma
and Legionella related species were identified in several samples using the T-RFLP ap-
proach.
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unclassified root
unclassified root
Figure 23: Phylogenetic tree ilustrating microbial community of lungs
associated with COPD in stable state. Different genera are denoted with
different colors with two exceptions: families Rhodocyclaceae and Lach-
nospiraceae represent the taxa of higher rank. Bacteria marked with red
circles were detected only in COPD patients, whereas other microbes are
the part of a core lung microbiome.
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4.5 Principal component analysis of detected microbial communi-
ties
It has become apparent in recent years, that the adaptation of highly variative statistical
tools from core data-analytic disciplines to microbial community analysis is needed. The
major focus of research in this area is on accurate discrimination and classification of
bacteria, and on understanding and describing the differences between communities.
PCA was performed with WEKA3 software [70] with the correlation (standardized)
option that first centers the TRFs and than divides each matrix entry by the standard
deviation for each TRF, thus producing a correlation matrix. Firstly, all identified species
were arranged to the genus level and organized in compliance with subject ID number
and relative abundance (in%) in the community. Then four different classifiers (Naive
Bayes, Multilayer perceptron, Support Vector Machine, and Random Forest) were ap-
plied in order to calculate the principal components of each class and design the classi-
fier according to the projection of the data on the subspaces spanned by these principal
components, corresponding to different classes (data not shown). The multilayer per-
ceptron classifier delivered the best results, separating all data sets into two distinct
groups with two exceptions (two healthy individual samples were identified as COPD
positive). This classifier consists of multiple layers of nodes in a directed graph, with
each layer fully connected to the next one.
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Figure 24: Biplot of the principal component analysis of the bacterial com-
munities from bronchoalveolar lavages of the COPD patients and healthy
individuals
Classification optimization yielded the results as shown in Table 12. Following phy-
lotypes were used to build the classifier model based on our data set consisting of 9 T-
RFLP analyzed BAL samples taken from healthy individuals and COPD patients respec-
tively: Neisseria, Corynebacterium, Staphylococcus, Bacillus, Mesorhizobium, Flavobac-
terium, Lysinibacillus, Lachnospiraceae, Streptomyces, Acinetobacter, Megasphaera, Pseu-
domonas, Clostridium, Sphingomonadales, and Clostridiaceae.
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Table 12: Classification results using a classifier and cross validation
based on optimization
TP Rate TP Rate Precision F-Measure Class Confusion Matrix
0.778 0 1 0.875 Healthy a b <– classified as
7 2 | a = healthy
0 9 | b = COPD
1 0.222 0.818 0.9 COPD
Out of 18 instances 16 (88.9%) were correctly classified. With the application of
Simple K-Means clustering we could further reduce the phylotypes retaining Bacillus,
Mesorhizobium, Flavobacterium, Streptomyces, Megasphaera and Clostridiaceae. Given
the TP and FP rates this genera combination is reliable for the COPD group. Mesorhi-
zobium was only detected in samples of healthy individuals. Classification solely based
on a prior feature selection via PCA did not create a good learning model as shown in
Table 13.
Table 13: Classification results using a NaiveBayes classifier and cross
validation based on prior feature selection
TP Rate TP Rate Precision F-Measure Class Confusion Matrix
0.333 0.333 0.5 0.4 Healthy a b <– classified as
3 6 | a = healthy
3 6 | b = COPD
0.667 0.667 0.5 0.571 COPD
Different variance proportion cutoffs did not significantly change the results. Re-
garding Pseudomonas and Lactobacillus we used our PCA results to create a biplot using
the R library (Figure 24).
4.6 In situ detection of bacteria
There is a core bacterial community in the lower region of the respiratory tract. But,
it is important to emphasize that the methods which were used in the present study
could deliver the information only about bacterial DNA present in BAL samples. The
question remains whether do these DNA fragments correspond to the leaving bacterial
cells colonizing the lung epithelium?
To clarify this question the FISH was preformed with universal eubacterial oligonu-
cleotide probe EUB338 on mice lung tissue sections. Figure 25 shows S. aureus cells
hybridized with EUB338. There is a clearly defined cocci-shaped pattern to the graph,
and this can be taken to mean that whole cells seem to be stained.
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Figure 25: Positive control for FISH. Pure 24h culture of S. aureus grown
in nutrient broth was heat fixed and hybridized with the all-bacterium-
specific EUB 338 probe. Spherical cells (red) were clearly to distinguishable
in 10 examined light fields of each sample. All hybridizations were per-
formed at 46 °C and wash step −at 48 °C. The glass slides with the stained
samples were examined on a fluorescence research microscope Olympus
BX53® (Olympus America Inc., Melville, New York, USA) using cellSens®
software control.
Specificity tests under stringent FISH conditions using planktonically cultivated cells
showed that the probe displayed the anticipated specificity. Cell permeabilization of
paraformaldehyde-fixed samples by exposure to lysozyme proved to be absolutely nec-
essary. Without lysozyme pretreatment the Gram-positive bacteria showed no fluores-
cence (data not shown). Another critical point appeared to be the RNase inhibitor. Its
presence in the hybridization buffer was essential for getting a strong fluorescent signal.
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Figure 26: Overview of the microbial colonization pattern showing single
bacteria localized under or on the epithelial layer. Some bacteria are seen
as single cells but most bacteria occur in clusters. Representative data from
the 10 paraffin-embedded mice trachea tissue sections (1µm in thickness)
of healthy mice are shown. Slides were dewaxed and hybridized with the
all-bacterium-specific EUB 338 probe. Red (Alexa647) represents bacte-
ria and blue (DAPI) represents tracheal cells. All hybridizations were per-
formed at 46 °C and wash step — at 48 °C. The glass slides with the stained
samples were examined on a fluorescence research microscope Olympus
BX53® (Olympus America Inc., Melville, New York, USA) using cellSens®
software control.
Figure 26 depicts that there were more bacteria under the epithelial layer than in
the aeriferous space.
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5 Discussion
The central aim that motivates this research is: to determine the compositional changes
in pulmonary microbial communities linked with COPD and to extend the knowledge
about the core lung microbiome. The evidence from this study suggests that a variety of
factors relate to stable bacterial colonization in the lower respiratory tract and also to
significant differences observed in COPD patients compared with healthy individuals.
5.1 Microorganisms can be detected in patients with AECOPD
Infections have an important role in the pathogenesis of COPD and AECOPD [151].
The identification of microorganisms in AECOPD is important to characterize the role
of specific microorganisms in the disease process and potentially to develop antimicro-
bial strategies. Infection and colonization are strongly associated with stable, chronic
COPD [150]. The role of microbes in AECOPD is complex. The acquisition of new bac-
terial strains from the environment appears to be one major factor in the initiation of
exacerbations [149, 12]. Classically, bacteria have been identified by culture, viruses
by culture, serology or immunofluorescence. In the past twenty years, NAT-based tech-
niques have been developed to detect viruses and bacteria in respiratory secretions.
These methods are very sensitive, however, they are limited due to relatively high costs,
the need for specialized equipment, and problems with false-positive and -negative re-
sults [35]. PCR-based NAT has been applied to detect atypical bacterial [52] and viral
pathogens [81] in AECOPD.
Sputum has routinely been used to determine the level of inflammatory markers
and to cultivate microorganisms in patients with AECOPD. The use of spontaneous or
induced sputum is limited by the difficulties of expectoration, low level of standard-
ization and contamination by the upper airways or saliva. Bronchoalveolar lavage or
protected specimen brush are invasive and generally not well tolerated by patients with
AECOPD [170]. EBC could potentially offer an opportunity to analyse the microbiom
of the lung. The use of EBC to monitor airway inflammation is based on the hypothe-
sis that it contains aerosolized particles from the airway lining fluid. It is known that
such factors as collection device, pattern of breathing, nasal and oral contamination can
influence the obtained results [27]. Data that is not normalized cannot be compared
from patient to patient and from study to study; this makes analysis of exhaled breath
condensate less attractive [130]. A high degree of within-subject variability has been
demonstrated for such EBC markers as pH value and leukotriene B4 in COPD patients
[93]. The pH of EBC is significantly more variable in these patients than in healthy
subjects. Although the detection of bacterial DNA in EBC was reported first in 1999,
over the last ten years there have been only a limited number of publications confirm-
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ing this statement. The majority of them present the negative results concerning the
bacterial and viral PCR-based detection in cystic fibrosis, pulmonary tuberculosis and
influenza patients [84, 59, 176]. The authors speculated about the possible reasons for
this and concluded that one major problem might be decreased recovery of bacterial
and viral nucleic acids in EBCs. Mycobacterium tuberculosis and perhaps other bacteria
are too large to be transported as nonvolatile particles in EBC [84]. EBC has been used
as the starting material for NAT-based techniques. There is only a limited amount of
data on the detection of microorganisms based on NAT from EBC available [57, 84].
The current study shows that DNA and RNA can be detected in EBC [185]. We used the
conventional PCR to identify bacteria (not the real-time quantitative PCR) since the dra-
matic differences in total DNA concentrations in EBC and sputum would not allow the
comparison of the differences in obtained data. Moreover, change in bacterial load is
unlikely to be an important mechanism for AECOPD [152]. Interestingly, a comparison
with the results from sputum showed that the detection patterns did not correlate well.
Several reasons could contribute to the divergent results: 1) The sources of sputum and
EBC could be different and thus different microorganisms could have been sampled.
The origin of EBC is not known, although the evidence suggests that it resembles not
only the bronchial part of the lower respiratory tract but also the alveolar part. A recent
comparison between EBCs and bronchoalveolar lavages concluded that the anatomical
origin of the material is difficult to be determined and that the results of both meth-
ods were hardly comparable [83]. 2) The location of microbial components (i.e., the
nucleic acids) might determine how easily they are included in the sample. While mi-
croorganisms are often located within sputum, an aerosilization process is necessary for
detection in EBC. Many other factors could contribute here, including volatility, solu-
bility, or charge of the molecule. 3) NA of specific microorganisms might be unstable
in sputum or EBC. 4) EBC might be insensitive to lung pathogens and the positive re-
sults might reflect false-positive detection of bacterial of the standard microflora from
the upper airways. H. influenzae, S. aureus and M. catarrhalis are found in the upper
respiratory tract of healthy individuals.
The current study shows that bacteria and viruses are present in the airways of
patients with AECOPD. It is well documented that exacerbation is associated with mi-
croorganisms, either with increased microbial load [179, 164], or with the acquisition
of new bacterial strains [151]. In agreement with known data, we detected viruses and
bacteria during AECOPD. One finding as a result of this data is that stable COPD pa-
tients are often also culture- or PCR-positive for these microorganisms [134, 150]. Our
study revealed that many patients with AECOPD show the presence of NA from more
than one microbial species indicative of co-infection. This is an interesting phenomenon
because it is known that bacteria and viruses interact in the induction of an inflamma-
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tory response [179, 127]. On the other hand ZETTERQUIST et al. have shown that EBC
nitrite mainly originates in the pharyngo-oral tract and its increase in cystic fibrosis is
possibly explained by a regional change in bacterial activity [186]. Identification of
nitrate reducing bacteria in EBC will prove this hypothesis. Thus, the detection of bac-
terial DNA in samples should be taken into account by interpretation of results due to
other biomarkers measured in EBC. EBC cannot be used to detect the viral pulmonary
pathogens. Our data supports the results obtained from influenza patients [59].
In conclusion, the current study demonstrates that EBCs can be used to determine
the presence of microbial NA in patients with AECOPD. This detection likely reflects the
presence of the corresponding microorganism. Interestingly, the results from EBC and
sputum do not correlate well. The study also reiterates that microbes have an important
role in the induction of AECOPD.
5.2 Polymicrobial communities in the respiratory tract
It is generally agreed today that there is a core bacterial microbiome in the lower respi-
ratory tract [56, 79, 75]. It demonstrates high individual diversity and detected species
are often considered to be also the part of oral cavity standard microbiota. Species
common to all sites in the mouth belong to the genera Gemella, Granulicatella, Strepto-
coccus, and Veillonella [2]. Against this background, the central question that motivated
this study is: whether the bacteria from the bronchial tree are present in these lower
regions of the respiratory tract or whether the data represents contamination during the
sampling procedure.
Bronchoscopy is a procedure performed with an instrument called the bronchoscope
in order to inspect the airways of the lungs. The domain of interest for the broncho-
scopist is that area of the respiratory tract found below the vocal cords. The broncho-
scope is inserted into the airways, usually through the nose or mouth, or occasionally
through a tracheostomy. This allows the practitioner to examine the patient’s airways
for abnormalities such as foreign bodies, bleeding, tumors, or inflammation. Specimens
may be taken from inside the lungs. The construction of bronchoscopes ranges from
rigid metal tubes with attached lighting devices to flexible optical fiber instruments
with real-time video equipment.
In the present clinical trial the flexible fiberoptic bronchoscope was used. The flexi-
ble bronchoscope is longer and thinner than a rigid bronchoscope. It contains a fiberop-
tic system or photochip that transmits an image from the tip of the instrument to an
eyepiece or video camera at the opposite end. The flexible bronchoscopy causes less
discomfort for the patient and the procedure can be performed easily and safely under
moderate sedation.
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The oral cavity and upper airways the surface of the bronchoscope is covered with a
variety of bacterial cells. In the present study, all the common oral genera were found in
the COPD patient group (see Figure 23), but in healthy individuals their presence was
limited only by two genera: Veillonella and Streptococcus (see Figure 22). On the other
hand, according to Tables 10 and 11, the T-RFLP analysis could detect three oral genera
in COPD patients (Veillonella, Gemella, and Streptococcus) and two genera (Veillonella
and Streptococcus) in the healthy volunteer group. Several explanations for this fact
have been offered. Detected oral microbial representatives made up not more than
9% of the total bacterial community. Even if the contamination occurred, all the other
ribotypes which were found actually referred to lower airway microbiome. Moreover,
there is no strong evidence that oral bacteria cannot persist in alveolar regions of lungs
as well. In the case of the above mentioned genera, the question of their including or
excluding into the core pulmonary microbiome needs further investigation. The genus
Terrahaemophilus was first detected in respiratory samples in a study focused on oral
and respiratory bacterial species associated with ventilator-associated pneumonia [19].
But the authors could not provide any body of evidence, that these bacteria play a role
in the pathogenesis of disease. In contrast to contamination hypothesis, the sequencing
data shows that oral bacteria such as E. saburreum and S. periodontii typically could
not be detected in COPD patient BAL samples. COENYE et al. in 2002 demonstrated
the genus Ralstonia to chronically colonize CF patients by using genotyping of serial
isolates recovered from the same patient [40]. In our study this genus was present only
in COPD patients. Other genera included Afipia, Brevundimonas, Curvibacter,Moraxella,
Neisseria, Undibacterium, Corynebacterium, Capnocytophaga, and Leptolyngbia.
Despite the fact that NAATs have made a major contribution to the improved etio-
logical diagnosis of pulmonary disorders [110] there are still some limitations. Since
only microbial DNA can be detected, there is a lack of information concerning impor-
tant parameters such as: quantity or bacterial load and antibiotic sensitivity of isolated
pathogens. Additionally, no isolates can be obtained for fingerprinting (by phenotypic or
genotypic methods). Quantitative real-time PCR (qPCR) leads the field in providing an
adequate solution for the problem of quantitative assessment of particular respiratory
pathogens. But there is no suitable gene target in microbial genome for the qPCR de-
sign. Although there are some attempts to use the16 S rRNA gene for this purpose [56],
unfortunately its copy number is a highly variable species-specific feature. The number
of 16 S rRNA gene copies per genome can vary between 1 and 15 [100]. To normalize
the qPCR data a standard curve using, for example, Helicobacter hepaticus DNA (a bac-
terium known to have only a single copy of the 16 S rRNA gene in its genome) can be
constructed. But in this case only the total number in a sample 16 S rRNA gene copies
can be evaluated. This provides no information about the total bacterial load.
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It is also important to emphasize that detected bacterial DNA does not necessarily in-
dicates the presence of living bacteria in the respiratory tract. Some studies showed that
structural components of bacterial cells, such as LPS or peptidoglycan constantly acti-
vate pattern recognition receptors on epithelial cells, dendritic cells and macrophages,
thus enabling the tolerance of the immune system and preventing constant inflamma-
tion [136]. This fact leads to the conclusion, that detection of bacterial DNA in respi-
ratory samples plays an important role in providing of stimuli, which induce immune
tolerance.
T-RFLP is a molecular approach that allows rapid comparison of the community
structure and diversity of different origins. This technique has been used for assessing
the diversity and structure of complex bacterial communities in various environments,
mainly being soil and water. In the present study T-RFLP analysis was used to charac-
terize and compare pulmonary microbiota present in BAL samples of 9 healthy subjects
and 9 patients with COPD.
T-RFLP using the restriction endonucleaseMspI analysis could assign different peaks.
But a number of restrictions of the present study and areas for future research should
be mentioned. First of all, it is a well-known fact that multiple species can be predicted
for the same TRF length and the identification of bacterial species can be improved
by analysis of digests with multiple restriction enzymes. HhaI, MspI and RsaI were
shown to have the best resolution rate in cutting the fragments of 16 S rRNA gene
[99]. Since only one endonuclease was used to digest the PCR products, some gaps in
community profiles could arise. By comparing the sequencing data with T-RFLP pro-
files some genera (Haemophilus, Methylophilus, Propionibacterium, Terrahaemophilus,
Eubacterium, and Centipeda for healthy individual group; Abiotrophia, Granulicatella,
Methylobacterium, Afipia, Brevundimonas, Curvibacter, Moraxella, Variovorax, Undibac-
terium, Rhodocyclaceae, Capnocytophaga, and Leptolyngbya for COPD patient cohort) are
missing in generated profiles. This can be enterpreted in several ways; the resolution of
MspI is not high enough to distinguish between all the presenting genera. Or the copy
number of 16 S rRNA gene is too low in this bacteria. In this case due to the low abun-
dance they could not be read as separate peaks by the software and thus were excluded
from the analysis.
Interestingly, Mycoplasma sp. and Legionella sp. were detected by T-RFLP, but not by
sequencing. Since the method of DNA extraction did not differ in both approaches, it is
rather difficult to find an explanation for this phenomenon. The used primer set (Ba27f
and Ba907r) possibly did not target conservative regions in their 16 S rRNA gene.
There is a growing body of evidence that indicated that changes in pulmonary mi-
crobial communities are linked to different pathological states. These changes may play
a key role in the pathogenesis and progression of airway obstruction and emphysema.
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This study indicated that T-RFLP analysis is useful for the assessment of diversity of
pulmonary microbiota and the rapid comparison of the community structure between
subjects with and without COPD.
Because T-RFLP does not offer sufficient information to confirm the phylogenetic
information of pulmonary microbial communities, the community structures were ana-
lyzed by sequencing. Sequencing is a procedure that is used to determine the order of
nucleotides in a particular DNA fragment (16 S rRNA gene). The sequencing technique
used for the present project relies on the Sanger dideoxy method, which was originally
developed in 1977 by Frederick Sanger and permits analysis of the target DNA up to
1 kb from the site of primer hybridization. This procedure generates single-stranded
DNA fragments terminating at each of four nucleotides (A, G, T, C), which are then
differently labeled with fluorophores that emit light at different wavelengths upon ex-
citation with a laser.
The directionality and antiparallel nature of all target DNA strands were consid-
ered before phylogenetic analysis (the plus strand delivered from bacterial isolates was
used).
The T-RFLP data provided rapid information about individual changes in pulmonary
microbial communities and revealed the presence of 9 core genera: Prevotella, Sph-
ingomonadaceae, Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veillonella,
Staphylococcus, and Streptococcus. Thus they could be well correlated with sequencing
analysis. Despite some differences (such as detection of untypical pathogens), T-RFLP
appeared to be a suitable tool for the pulmonary microbiome characteristic.
The sequencing allows the construction of multiple sequence alignments that are
useful for depicting evolutionary relationships among and between genes from differ-
ent bacteria. By rooting the phylogenetic trees all bacteria were classified into distinct
clades (internal nodes) (Figure 22, 23). For examples, all 24 representatives of Pre-
votella sp. detected in healthy individual cohort formed one clade and are said to be
monophyletic. A great deal of emphasis is placed on whether a set of taxa forms a clade
and thus can be classified based on evolutionary ancestry. This is the most important
advantage of sequencing compared with T-RFLP analysis. In study of STRESSMANN et al.
T-RFLP analysis as well as sequencing were applied to study respiratory samples of cystic
fibrosis patients [165]. The detection of species by clone sequencing that corresponded
to T-RF band lengths in individual patient’s profiles ranged from 13% to 67%.
5.3 Eukaryotic DNA blocks the PCR amplification of 16 S rRNA gene
It is a well-known fact that the presence of total eukaryotic DNA can inhibit the PCR
amplification of bacterial nucleic acids. This could be due to competitive non-specific
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hybridization of a large amount of human DNA with 16 S rRNA gene-specific primers
[111]. Moreover, the inhibition may occur as a simple consequence of a decrease in
the rate of diffusion of all macromolecular components of the reaction mixture in the
presence of large amounts of long strands of host DNA. In the present work, the total
DNA was used as a template for the PCR as well. The sensitivity of PCR using primers
Ba27f / Ba907r was not affected by human DNA (see Figure 9). In the case of BAL
samples, the used primer set could not provide sensitive enough results in the case of
human and mice lung tissues (data not shown). There were unspecific by-products
generated from eukaryotic DNA, which were observed.
Additionally, PCR-induced artifacts in microbial diversity studies remain an impor-
tant issue in the search for patterns and the extent of microbial diversity. The basic types
of PCR artifacts have been shown in controlled laboratory studies and can be divided
into two categories: those resulting in sequence artifacts (PCR errors), and those skew-
ing the distribution of PCR products due to unequal amplification (PCR bias) or cloning
efficiency. Sequence artifacts may arise due to the formation of chimerical molecules,
the formation of heteroduplex molecules, and TaqDNA polymerase error [3]. Thereafter
the Phusion Hot Start proofreading DNA polymerase was used. It allowed the minimiza-
tion of the sequence artifacts. To minimize chimeras, the smallest possible number of
PCR amplification cycles should be carried out (e.g., until a band is barely visible on
agarose gels). But due to the used sample type (total DNA containing eukaryotic part)
it was not profitable to decrease the cycle number to less than 40.
By and large, the PCR conditions for amplification of 16 S rRNA gene fragment were
optimized to possibly avoid the artifacts and bias without losing its sensitivity.
5.4 Sequencing: confidence and bias
A phylogenetic tree is considered to be well supported if it has passed statistical tests
measuring significance. An accepted method used to assess confidence is called boot-
strapping. In the most general sense, bootstrapping is a statistical procedure in which
raw data are re-assembled numerous times so as to estimate model parameters such as
the mean or variance of the set of data. Both phylogenetic trees presented in this work
were bootstrapped 1000 times.
Nowadays, sequencing projects simply download all available genomic data from
public databases, such as the NCBI GenBank, RDP or Greengenes. Although this ap-
proach gives a reasonable first approximation of the diversity within each species, there
are problems associated with the marked sampling biases in public data. For instance,
there is a particular overabundance of sequenced pathogen strains in comparison to
their non-pathogenic relatives. Another issue is the variability of metadata associated
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with each genome. The annotation of gene and other sequence features is often vari-
able and dependent on the year of publication and the research group. Also, important
information on strain provenance and phenotype is often unavailable. There are no
accepted standards for the level of sequence read coverage necessary to produce a good
alignment. Genome projects can vary considerably in the number of sequencing errors.
Artifacts, such as frame shifts, can remove true coding sequences from consideration as
part of a pan-genome.
Clones libraries construction approach has considerably increased our understand-
ing of the role of bacteria in initiating, progression and spreading of different diseases
[21, 36, 37, 43, 51, 63, 87, 105, 124, 189]. But databases used to classify the sequences
still need to be improved.
5.5 Bacterial presence in lower airways is confirmed by FISH
Mouse tracheal cross-sections were used for FISH analysis. In the present study, the pro-
cedure for the in situ analysis of the distribution of bacteria in mice lung tissue samples
was optimized for the first time. Key elements of the procedure are: adequate fixation,
optimal permeabilization, and careful selection of the best combination between probe,
fluorescence label, and formamide concentration. The major finding was that bacteria
persist under the epithelial layer in the trachea.
The FISH procedure was performed on human and mice lung tissue sections (data
not shown). Unfortunately, no clearly distinguishable positive signal could be detected.
One possible explanation of this fact is that lung tissues are known to have an extremely
high autofluorescence level. That’s why a positive signal could just be overlapped by
one produced by proteins in lung tissues. Use of new methods such as FISH affords
experience in FISH microscopy and adherence to evaluation standards. FISH signals
within complex eukaryotic tissues can generate a vast number of unspecific fluorescence
phenomena [169].
M. catarrhalis and H. influenzae can be internalized in respiratory epithelial cells
[158, 109]. This new aspect of the interplay of respiratory opportunistic pathogens
may be essential to its chronic persistence inside the host.
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6 Conclusion
The present study enhances understanding of the role of pulmonary microbial commu-
nities in health and disease. The 18 BAL samples obtained from healthy individuals and
COPD patients were examined for the presence of a variety of bacteria. It appears that
the lower respiratory tract is colonized by microbes, that can stably persist in it.
The T-RFLP approach illustrated the high qualitative and quantitative diversity of
the microbiome structure in different individuals. Almost all studied samples demon-
strated the presence of both common and unique ribotypes. No distinctive pattern in
microbial composition could be seen either in healthy persons or in COPD patients. But,
the presence of such genera as Mycoplasma (6 positive samples), Pseudomonas (5 posi-
tive samples) and Staphylococcus (5 positive samples) were highly correlated with dis-
ease. Patients with ID numbers 4 and 9 had probable monoinfection with Pseudomonas
sp.. This led to the reduction of standard microbiota diversity. This fact can be used
as a basis for a predictive model in using T-RFLP in rapid diagnostic tests. Interest-
ingly, the presence of genus Lactobacillus completely correlated with the distribution of
Megasphaera between healthy individuals and with the occurrence of Mezorhizobium,
Pseudomonas and Streptomyces. The formation of complex microbial associations within
the respiratory tract could provide the explanation for this phenomenon. Genera such
as Mycobacterium, Lysinibacillus, Gemella, Treponema, Streptobacillus, and Alkaliphilus
were characteristic of the COPD state. On the other hand, Mesorhizobium, Microbacte-
riaceae, Micrococcus, Veillonelaceae, Rhizobium, Stenotrophomonas, and Lactococcus pre-
sented exclusively in healthy individual cohort. Some significant quantitative changes
were also found in the distribution of genus Neisseria. Its presence in lower amounts
was characteristic of steady state. Increasement of Neisseria load was linked with COPD.
Sequencing data, supported by T-RFLP analysis, revealed the presence of core mi-
crobiome in the lower respiratory tract. The key genera included Prevotella, Sphin-
gomonas, Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veillonella, Staphy-
lococcus, and Streptococcus.
One of the main findings of this project is the detection of probiotic bacteria of the
genera Lactobacillus and Lactococcus in respiratory samples. Due to their known role in
the maintenance of the homeostasis, immunomodulatory and antiinflammatory activi-
ties; the results obtained can be used in the probiotic bacteria based drugs production.
Modern microbiology is moving into the new “population genomics era”, when a
typical microbial pathogen (1Mb to 6 Mb) can be sequenced in just one day [38].
More than 1600 bacterial genomes are now available in publicly accessible genome
sequence databases. This needs the reevaluation of the basic concepts in clinical diag-
nostics as well as in the fundamental field of microbiological research. Particularly, the
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whole-genome sequencing projects have led to the idea of the species “pan-genome”
[23, 86]. This means that each microbial genome consists of two principal parts: the
core genome and the dispensable genome. The core genome is represented by the set
of genes conserved across all strains in a species. It encodes the basic functions and
features necessary for basic survival. The dispensable genome contributes to the di-
versity within the species, including niche adaptation, antibiotic resistance, virulence,
transmissibility etc. In terms of pathogen detection and subtyping, discriminating the
core genome is important for the identification of diagnostic targets of all bacteria in a
taxon. The dispensable genome is helpful for identifying particular key genes that can
be used to target only pathogenic strains. Important changes such as gene copy number
alterations (through deletion, tandem duplication or site-specific recombination) can be
registered by means of comparative population genomics. Knowing detailed informa-
tion about the composition of microbiota in the lower respiratory tract will improve the
therapeutical approaches of personalized medicine. Especially once it has been proved
that microbiota in the lungs have individual differences.
The whole genome sequencing will become soon a routine epidemiological approach
[117]. This data will deliver a fundamental new understanding of microbial genetics
and ecology [168, 123]. For the routine praxis simultaneous detection of two or more
genes of interest using novel microfluidic digital PCR will become more relevant [116].
Recently it was shown that three predominant enterotypes could be distinguished in
the human population [15]. Future systemic studies may provide new links between
the intestinal and respiratory microbiota. Defining the complexity of the human micro-
biome in health and disease will enhance the understanding of multiple pathological
mechanisms and facilitate the development of novel diagnostic tools and therapeutic
interventions.
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Nomenclature
16 S rRNA gene a section of prokaryotic DNA found in all bacteria and archaea
ALF alveolar lining fluid
ASL airway surface liquid
Bacteroid symbiotic form of the nitrogen - fixing bacteria
COPD chronic obstructive pulmonary disease
Diphteroid pleomorphic non - motile, Gram - positive rods of the Corynebac-
terium and Propionibacterium genera
DNA deoxyribonucleic acid
Endonuclease enzyme which cleaves the phosphodiester bond within a polynu-
cleotide chain
FAM 6-carboxy-fluorescein
FISH fluorescence in situ hybridization
GOLD the Global initiative for chronic Obstructive Lung Disease
LPS lipopoligosaccharide
MAMPs microbe - associated molecular patterns
NCBI National Center for Biotechnology Information
NLR NOD like receptor
OTU operational taxonomic unit, a terminal node in phylogenetic anal-
ysis
PCA principal component analysis
PCR polymerase chain reaction
RDP ribosomal database project
RLR retinoic acid - inducible gene (RIG)-I-like receptor
ROS reactive oxygen species
rRNA ribosomal ribonucleic acid
T-RFLP terminal restriction fragment length polymorphism
TLR toll like receptor
TNF tumor necrosis factor
TRF terminal restriction fragment
Ub ubiquitin
WHO World Health Organization
Index
α1 - antitrypsin, 2
16 S rRNA gene, 12, 14, 25, 28, 31, 42
454 pyrosequencing, 15
A - tailing, 28
AECOPD, 2
airway obstruction, 10, 11
airway surface liquid, 7
alignment, 32
anaerobe, 8
antifade, 35
bacteria, 2, 3, 8, 10, 11, 16, 32
bacteroid, 8
BAL, 9, 13, 21, 37, 61, 62, 64, 66
BLAST, 14, 31
bootstrapping, 49
chimera, 32
colonization, 2, 3, 8, 10, 11, 34
commensal, 5, 7
COPD, 1–3, 9, 10, 15, 16, 18, 20, 41, 61
core genome, 67
CRP, 20
culture method, 11
cystic fibrosis, 13
diphteroid, 8
distance matrix, 33
DMSO, 30
DNA, 11, 13–15, 21, 28, 32, 37, 64
E. coli, 22, 28, 29, 31
EDTA, 34
emphysema, 62
epithelial cell, 5
EUB338 probe, 34, 55
facultative anaerobe, 8
FEV, 20
FISH, 33, 55
gap, 31, 32, 42
GenBank, 32, 48, 64
GOLD, 1
Greengenes, 64
H. influenzae, 3, 10, 11, 13
IL-8, 2
inflammation, 2, 3, 5, 6, 10
Lactobacilli, 7, 42, 43, 66
LB agar, 29
LPS, 10
lung, 7, 10
M. catarrhalis, 3, 4, 8–11
MAMP, 6
mass spectrometry, 15
metagenomic sequencing, 15
MiCA3, 42
microarray, 16
microbial community, 12, 16, 42, 62
microbiome, 15
microbiota, 1, 8, 9
mounting medium, 35
nasopharynx, 8, 11
NCBI, 31, 64
neighbor-joining method, 32, 49
next-generation sequencing, 15
NF-κB, 4–7
NLR, 5
NOD, 4, 5
OTU, 13, 33
P. aeruginosa, 9, 10, 13
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Index
paraffin section, 33
pathogen, 10
PCA, 35
PCR, 11, 12, 16, 22, 37, 64
persistence, 10
pGEM -T Easy Vector, 28, 31
polymerase, 28
PPAR, 7
Prevotella, 42
primer, 12, 29, 42
PRR, 4
RDP, 14, 41, 64
Rel A, 7
restriction endonuclease, 13
ribotype, 42
RLR, 5
ROS, 7
ROX standard, 25
S. aureus, 8, 10, 34
S. pneumoniae, 9–11
S. typhimurium, 7
Sanger-based sequencing, 15
sequencing, 14, 15, 64
Shannon-Wiener diversity index, 27
SOB medium, 29
SOC medium, 31
species identification, 12
sputum, 9, 10
T-RFLP, 13, 25, 27, 41, 42, 51
TLR, 4, 5
TNF, 2, 10
TRF, 27, 42
ubiquitin, 7
vector contamination, 32
Veillonella, 42
WHO, 2
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Patientenaufklärung, COPD Bakteria, Version HOM 5 - 2010
Homburg, am 16 / 06 / 2010
Patienteninformation zur Studie
„Untersuchung des Einflusses chronischer bakterieller Kolonisation auf den
Krankheitsverlauf in Patienten mit Asthma und chronisch obstruktiver Lungenerkrankung
(COPD)”
Studienleiter: Prof. Dr. Dr. Robert Bals an der Klinik für Innere Medizin,
Schwerpunkt Pneumologie des Universitätsklinikums des Saarlandes
Kirrbergerstr. 1, 66421 Homburg
Sehr geehrte Patientin, sehr geehrter Patient,
Dieses Informationsblatt soll dazu diesen, Sie über die bevorstehende Studie zu
informieren und Sie um Ihre Teilnahme zu bitten. Bevor Sie sich entscheiden, an
dieser Studie teilzunehmen, lesen Sie bitte dieses Informationsblatt sorgfältig durch. Es
beschreibt Einzelheiten der Studie und was von Ihnen bei einer Teilnahme der Studie
erwartet werden würde.
Worum geht es bei dieser Studie ?
Patienten mit Asthma oder der chronisch obstruktiven Lungenerkrankung (COPD)
sind oft von Infektion der Atemwege betroffen. Auch führen diese Infektionen dazu,
dass sich die Erkrankung verschlechtert.
Im Rahmen der Studie soll untersucht werden, ob die Atemwege von Patienten mit
Asthma oder COPD mit Bakterien besiedelt sind. Dies soll mit Ergebnissen von Personen
verglichen werden, die nicht an Asthma oder COPD erkrankt sind. Dazu sollen neue
Methoden verwendet werden, da bisher verwendete Verfahren nicht empfindlich genug
sind.
Was kommt auf Sie zu ?
Aus medizinischen Gründen werden Sie sicCurriculum vitaeh einer Bronchoskopie
mit Lungenspülung unterziehen. Das überschüssige Material, das nicht für die Diag-
nostik verwendet wird, verwenden wir für die Studie. Zur Untersuchung der Entzün-
dungsaktivität im Körper ist es notwendig, dass Sie einen Fragebogen ausfüllen. Weit-
erhin benötigen wir die Daten einer aktuellen Lungenfunktion.
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Welche Nebenwirkungen sind möglich ?
Alle Maßnahmen sind risikofrei oder risikoarm.
Können Sie aus dieser Studie wieder ausscheiden ?
Die Teilnahme an der Studie ist freiwillig. Sie können jederzeit und ohne Angabe von
Gründen Ihre Einwilligung zurückziehen und die Studie abbrechen, ohne dass Ihnen
Nachteile bei der späteren medizinischen Versorgung entstehen.
Wie vertraulich werden die Daten behandelt ?
Die im Rahmen der Studie aufgezeichneten Daten sowie die Untersuchungsergeb-
nisse werden ohne Ihre persönlichen Daten, d.h. anonymisiert, ausgewertet. Eine Of-
fenlegung oder Übermittlung Ihrer Daten findet nicht statt. Beim Umgang mit den
erhobenen Daten werden alle Grundsätze des Datenschutzes gewahrt.
Falls Sie Interesse haben, erklären wir Ihnen das Vorgehen gerne im Detail. Wir
teilen Ihnen auch gerne die Ergebnisse unserer Untersuchungen mit.
Falls Sie weitere Fragen haben sollten, können Sie jederzeit den Studienleiter, Herrn
Prof. Dr. Dr. Robert Bals, erreichen (Tel. 06841 16 2600).
Prof. Dr. med. Dr. rer. nat. Robert Bals
Klinik für Innere Medizin V - Pneumologie
Tel. +49 (0) 6421 286 4994
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Patienteneinwilligung, COPD Bakteria
Version vom 2 - 2006
Einwilligung
Ich, , geb. am
wohnhaft in
PLZ Ort Telefon
wurde von Herrn / Frau über Ziel und Ablauf der
Studie:
„Untersuchung des Einflusses chronischer bakterieller Kolonisation auf den
Krankheitsverlauf in Patienten mit Asthma und chronisch obstruktiver Lungenerkrankung
(COPD)“
umfassend aufgeklärt. Die Aufklärung wurde mir zusätzlich schriftlich in Form einer
Patienteninformation übergeben. Ich habe den Inhalt der Aufklärung verstanden und
zur Kenntnis genommen, dass ich bei weiteren Fragen jederzeit meinen behandelnden
Arzt oder den Studienleiter (Dr. Dr. Robert Bals - an der Klinik für Innere Medizin,
Schwerpunkt Pneumologie des Universitätsklinikums des Saarlandes, 66421 Homburg,
Tel +49 (0) 64841 16 23600) ansprechen kann. Des Weiteren ist mir bekannt, dass
ich die Untersuchung jederzeit, ohne Nennung von Gründen und ohne persönliche
Nachteile, beenden kann. Ich werde dies meinem behandelnden Arzt sofort mitteilen.
Mir ist bekannt, dass für diese Studie keinerlei personenbezogene Daten gesammelt
oder gespeichert werden, die Rückschlüssen über meine Person erlauben würden. Hi-
ermit erkläre ich meine Einwilligung zur freiwilligen Teilnahme an der Untersuchung.
Ort, Datum Unterschrift des Patienten
Ort, Datum Aufklärender Arzt
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Erfassungsbogen 16s Heidelberg
Seite 1, 10-10-2007
Erfassungsbogen:
Nummer
Raucher
Ja Packungsjahre
Nein
COPD
Ja Erstdiagnose
Nein
Infektionsparameter
CRP:
Leukozyten:
Lungenfunktion
FEV 1:
VC:
FVC:
TLC:
SR:
Blutgase
pH:
pO2:
pCO2:
Weitere Diagnosen
Aktuelle Medikation
Durchgeführte / geplante Operation
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Publications and presentations
Parts of this work have been revealed in the following publications:
1. T. Zakharkina, E. Heinzel, J. Pauling, J. Baumbach, and R. Bals. Standard lung
microbiota in healthy individuals and COPD patients (in preparation)
2. T. Zakharkina and R. Bals. The Role of Pathogenic and Commensal Bacteria in
Airway Epithelial Barrier Homeostasis (in preparation)
3. Zakharkina T., Koczulla R., Mardanova O., Hattesohl A., and Bals R. Detection
of microorganisms in exhaled breath condensate during acute exacerbations of
COPD. Respirology, 16: 932–8, 2011
4. C. Herr, T. Greulich, R. A. Koczulla, S. Meyer, T. Zakharkina, M. Branscheidt,
R. Eschmann, and R. Bals. The role of vitamin D in pulmonary disease: COPD,
asthma, infection, and cancer. Respir Res, 18: 12–31, 2011
5. C. Hess, C. Herr, C. Beisswenger, T. Zakharkina, R. M. Schmid, and R. Bals.
Myeloid RelA regulates pulmonary host defense networks. Eur Respir J, 35: 343–52,
2010
Key presentations (related to this work):
1. 51st Congress of the German Society for Pneumology and Ventilatory Support
(Hannover, Germany, March, 2010)
2. American Thoracic Society International Conference (San Diego, USA, May, 2009)
3. European Respiratory Society Annual Congress (Vienna, Austria, September, 2009)
4. 50th Congress of the German Society for Pneumology and Ventilatory Support
(Mannheim, Germany, March, 2009)
5. Annual Meeting of the Cell Biology Section of the German Society for Pneumology
and Ventilatory Support (Freiburg, Germany, November, 2008)
6. Summer School “Pathogen-Host Interactions at Cellular Barriers” (Muenster, Ger-
many, June, 2008)
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